WO1998048767A1 - Humectant, and cosmetic preparation and medicine both containing the same - Google Patents

Humectant, and cosmetic preparation and medicine both containing the same Download PDF

Info

Publication number
WO1998048767A1
WO1998048767A1 PCT/JP1998/001929 JP9801929W WO9848767A1 WO 1998048767 A1 WO1998048767 A1 WO 1998048767A1 JP 9801929 W JP9801929 W JP 9801929W WO 9848767 A1 WO9848767 A1 WO 9848767A1
Authority
WO
WIPO (PCT)
Prior art keywords
water
organic solvent
fraction
skin
moisturizing
Prior art date
Application number
PCT/JP1998/001929
Other languages
French (fr)
Japanese (ja)
Inventor
Yoshio Furusawa
Original Assignee
Teikoku Hormone Mfg. Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Hormone Mfg. Co., Ltd. filed Critical Teikoku Hormone Mfg. Co., Ltd.
Priority to JP54682098A priority Critical patent/JP4424759B2/en
Publication of WO1998048767A1 publication Critical patent/WO1998048767A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/55Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/006Antidandruff preparations

Definitions

  • the present invention relates to a novel humectant, a humidifying method using the humectant, and cosmetics and pharmaceuticals containing the humectant. More specifically, the present invention is a novel moisturizer that has excellent moisturizing properties, has high durability of moisturizing function, can impart moist feeling and smoothness to skin and hair, and is safe for the human body.
  • the present invention relates to a method for moisturizing skin and hair using the humectant, and to cosmetics and pharmaceuticals containing the humectant. Skill
  • Skin cosmetics are generally prepared by blending a hydrophilic skin moisturizer and an oily emollient to give the skin adequate moisture and oil to prevent the skin from drying out. You.
  • polyethers such as polyethylene glycol and polypropylene glycol, glycerin, and sorbitol have been used as the hydrophilic skin moisturizer, but in recent years, natural moisturizing factor (NMF) has been used.
  • NMF natural moisturizing factor
  • Amino acids, sodium pyrrolidonecarboxylate, urea, sodium lactate, etc., and natural high molecular weight compounds such as sodium hyaluronate and salivary gland mucin have been used.
  • moisturizers such as polyethers, glycerin, and sorbitol have the drawback of being dermatologically heterogeneous, and also have the disadvantage of removing water from the outermost layer of the skin, the stratum corneum. NMFs may be absorbed and rather cause skin to lose moisture. NMFs, which have been used in recent years, are substances derived from natural products, but they have a poor feeling on use and have a poor moisturizing effect. There are drawbacks such as On the other hand, sodium hyaluronate is currently used in many cosmetics and gives a skin a "moist feeling" and "smoothness" in a concentration range of about 0.02 to 0.1% by weight. Its usefulness has been highly evaluated. In addition, for safety testing In the range of 2 to 3% by weight, no local irritation or sensitization was observed in laboratory animals, and in human patch tests, it was safe even at a concentration of 1% by weight. Has been confirmed.
  • Salivary gland mucins also have an excellent moisturizing effect, and their "moistness” and “smoothness” on the skin are evaluated as being superior to sodium hyaluronate. It has been confirmed that salivary gland mucin has moisturizing and emulsifying effects and is highly safe for the human body, and can be said to be a fairly ideal moisturizer.
  • Salivary gland mucin is a glycoprotein that is biosynthesized and secreted by the salivary glands of mammals, for example, pests, pomas, bushes, and sheep, such as the submandibular, parotid, and sublingual glands. It has an inherent viscosity depending on the type of animal and is obtained as a macromolecule containing a large amount of sialic acid and having a molecular weight of about 100,000 to 100,000.
  • cosmetics containing sodium hyaluronate and salivary gland mucin improve the feeling of use, but because both components are easily decomposed, the molecular weight decreases over time, and the moisturizing property and viscosity decrease.
  • Another disadvantage is that the moisturizing film is easily removed by washing with water or hot water.
  • liquid oils such as liquid paraffin and petrolatum are used as emollients, but when these emollients are added to such an extent that they prevent normal evaporation of water from the epidermis, unpleasant feeling due to stickiness And lacks usefulness as a skin moisturizer. Disclosure of the invention
  • the first object of the present invention is to (1) exert a moisturizing property in an extremely small amount, and can be blended into various cosmetic bases and bases for external preparations for pharmaceuticals.
  • Skin and (3) It can give a moist feeling and "smoothness” to hair and hair.
  • (3) It does not give a feeling of incongruity such as "stickiness” or “sharpness” like conventional oily emollients.
  • Moisturizing. The moisturizing film is not removed even after washing with water or hot water several times, (6) It is highly safe for the human body. Is to provide a suitable humectant.
  • a second object is to provide a method for moisturizing skin and hair using the humectant
  • a third object is to provide cosmetics and medicines containing the humectant. It is to be.
  • the present inventors have conducted intensive studies to achieve the above object, and as a result, many animals lick their bodies with their tongues and groom, and when saliva dries, beautiful and smooth shiny hair is obtained. Focusing on the fact that the wound is moisturized with the tongue, preventing dryness and accelerating the healing of the wound, a certain method is used from the parotid gland secretion of mammals.
  • the separated components are (a) extremely moist, and exhibit a moisturizing function, and are safe for the human body.
  • B) Even in powder form, they dissolve in water and apply to the skin to exert a moisturizing function.
  • C It can be used by blending it with various cosmetic bases and bases for external preparations for medicines. Lotion, base for external medicines, etc.
  • a moisturizer characterized by containing, as an active ingredient, a fraction that precipitates at a water-miscible organic solvent concentration of 60% (v / v) or higher in the parotid secretion of mammals.
  • a method for moisturizing the skin comprising applying the humectant of (1) to the skin
  • a moisturizing method for hair and scalp which comprises applying the moisturizing agent of (1) to the hair or scalp or both.
  • a cosmetic comprising a cosmetic base and a fraction that precipitates at a water-miscible organic solvent concentration of 60% (v / v) or higher in the parotid gland secretion of a mammal.
  • the humectant of the present invention contains, as an active ingredient, a substance derived from the parotid fluid of a mammal, and the mammal is not particularly limited. Although it is preferable to take the secretion fluid into consideration, such as ease of collection, amount of secretion (1 to 50 to 60 liters is secreted in one case), economy, etc. .
  • Saliva secreted into the mouth of mammals is a mixture of secretions from the parotid, submandibular and sublingual glands.
  • the ratio of salivary gland secretion to its secretion is about 70% by weight of parotid gland, 5% by weight of submandibular gland, and 25% by weight of sublingual gland.
  • the secretion of the mammal used in the present invention is limited to that secreted from the parotid gland, and is substantially free of the secretion secreted from other salivary glands, the submandibular gland and the sublingual gland Things.
  • Saliva as a mixture contains mucous and serous components, but the parotid gland secretion, which is the secretion from the parotid gland, is known to be serous and mostly water. ing. To date, only “all saliva” as a mixture has been studied for "saliva”, and little has been done on the secretions of the three glands described above. The present inventors have studied the secretions obtained from the salivary glands and found out that the parotid secretions contained a component having an extremely excellent moisturizing function.
  • an incision is made on the skin below the animal's parotid and the oral surface Expose the parotid gland duct near the skin and make a small incision in the parotid gland duct so that the tip of the forcenula can be inserted. Guide the force through the incision in the skin, and insert the tip of the force neuron from the incision in the parotid duct toward the parotid gland.
  • the incision wound on the skin is closed while the cannula is fixed with adhesive tape.
  • a receiver can be placed on the opposite end of the force neuron to collect the parotid gland fluid that flows off naturally.
  • the preservatives to be added include ordinary preservatives, for example, benzoic acids, paraoxybenzoic acids, dehydroacetic acids, sorbic acids, phenols, alcohols, sodium, rogens, glutaraldehydes,? -Probio Lactones and the like, or a mixture thereof.
  • it is odorless or one which can easily be removed in the subsequent step even if it has an odor, and paraoxy-benzoic acids are particularly preferred.
  • the humectant of the present invention is obtained by mixing a mammalian parotid gland secretion with a water-miscible organic solvent, and a fraction that precipitates at an organic solvent concentration of 60% (v / v) or more (hereinafter, the humectant fraction). ) May be contained as an active ingredient.
  • the reason for setting the organic solvent concentration to 60% (v / v) or more is as follows. As the organic solvent is added to the parotid gland secretion, the solubility of the moisturizing components in the parotid gland secretion decreases and sedimentation begins to occur.
  • the effective amount of organic solvent added is defined as the amount at which this precipitate can be substantially recovered, which is about 60% (v / v) or more. Therefore, the amount of addition varies slightly depending on the type of organic solvent, but in the case of the present invention, if the amount of addition of the organic solvent is less than 60% (v / v), practical precipitation cannot be expected. .
  • the concentration of the organic solvent is not particularly limited as long as it is 60% (v / v) or more, but considering the amount of formed precipitate and the economics of using an excessive amount of the organic solvent,
  • the concentration of the organic solvent is preferably about 63 to 80% (v / v), and more preferably about 65 to 75% (v / v).
  • the parotid gland secretion collected as described above, or after filtration, is put into an extractor, and the water-miscible organic solvent is stirred preferably under cooling (about 0 to 15 ° C).
  • the obtained moisturizing fraction may be used as it is, but it is dehydrated and dried to obtain a powder. It is advantageous to use it.
  • As a method of dehydration there is a method of further adding a water-miscible organic solvent to the obtained fraction.
  • As a drying method there are an aeration method, a decompression method, and the like. These methods can be combined, and further heating can be applied.
  • water-miscible organic solvent examples include acetone, ethanol, methanol, and isopropanol. These may be used alone or in combination of two or more. Is particularly preferred.
  • the yield of the moisturizing fraction depends on the health of the animal from which the parotid gland secretion is collected, but is generally 0.1% as a dry fraction relative to the parotid gland secretion. It is about 5 to 0.7% by weight.
  • the nitrogen content and protein content in the dry and moisturizing fraction depend on animal health and the like, but are generally in the range of 0.05 to 0.4% by weight. And 0.4 to 3% by weight.
  • the substance having a moisturizing function of the moisturizing fraction has not yet been identified and is not necessarily a single substance.
  • mucopolysaccharides such as hyaluronic acid and salivary gland mucin It is considered to be a substance different from the above.
  • the moisturizing fraction separated from the parotid gland secretion of the mammal has the following properties.
  • the humectant of the present invention contains the humectant fraction as an active ingredient
  • the humectant may contain a conventionally known humectant component, if desired.
  • Known moisturizing components include, for example, polyethers such as polyethylene glycol and polypropylene glycol, polyhydric alcohols such as glycerin, 1,3-butylene glycol, propylene glycol, and sorbitol, and NMFs. Specific examples thereof include -amino acids, urea, sodium lactate, sodium borolidone carboxylate, mucopolysaccharides such as hyaluronic acid and chondroitin sulfate, and proteins such as collagen and elastin.
  • the moisturizing method of the present invention has two aspects. One is a method of applying the moisturizing agent of the present invention to the skin to moisturize the skin, whereby the skin has a “moist feeling” and “smoothness”. Is given.
  • the other is a method of applying the humectant of the present invention to the hair and / or scalp and moisturizing them, whereby the surface condition of the hair is improved and the slip on the hair surface (so-called comb) As expected), hair dressing is improved and drying of the scalp is improved, and itching and dandruff are suppressed.
  • the form of the humectant at the time of application is not particularly limited, and for example, a humectant can be used as a cosmetic in various forms described below or as an external preparation in various forms.
  • the cosmetic of the present invention contains a cosmetic base and the moisturizing fraction separated from the above-mentioned mammalian parotid secretion.
  • the amount of the moisturizing fraction (dry state) contained in the cosmetic of the present invention depends on the form of the cosmetic and the presence or absence of other moisturizing components, but is usually 0.0 based on the total amount of the cosmetic. 0 to 2% by weight. If the content is less than 0.001% by weight, the moisturizing function may not be sufficiently exhibited, and if it exceeds 2% by weight, no improvement in the effect is recognized for the amount, and it is economically disadvantageous. Becomes Consider the moisturizing effect and economy The preferred content is in the range of 0.05 to 0.2% by weight.
  • the base used in the cosmetic of the present invention is not particularly limited, and is appropriately selected according to the desired form of the cosmetic from various components conventionally used as the base in cosmetics of various forms. You can choose.
  • the form of the cosmetic of the present invention is not particularly limited, for example, skin cosmetics such as lotion, milky lotion, creams, packs, lotions, lipsticks, foundations, skin cleansers, etc., hair conditioner, hair rinse, Hair cosmetics such as hair tonics, hair creams, and hair lotions can be mentioned, and the moisturizing fraction can be blended whether the base is aqueous or oily.
  • a hair cosmetic in which the moisturizing fraction is blended with a hair cosmetic base has an excellent effect of keeping the hair and the scalp healthy.
  • the hair By improving the surface condition of the hair, the slip on the hair surface (so-called comb-like) is improved and the riding of hair cosmetics is improved. It can also improve scalp drying and reduce itching and dandruff.
  • the cosmetic of the present invention may contain, if desired, various components conventionally used in cosmetics, for example, oils, surfactants, emulsifiers, alcohols, other moisturizing components, thickeners, preservatives, and antibacterial protection.
  • Cosmetics for example, oils, surfactants, emulsifiers, alcohols, other moisturizing components, thickeners, preservatives, and antibacterial protection.
  • oil component examples include liquid oils such as castor oil, olive oil, jojoba oil, camellia oil, solid oils such as hardened castor oil, lanolin, whale wax, beeswax, carnauba wax, waxes such as candelilla wax, squalane, Examples include hydrocarbons such as petrolatum, liquid paraffin, sericin, and paraffin.
  • surfactant examples include POE sorbin ester such as polyoxyethylene (POE) sorbin monooleate, sorbin ester such as sorbitan monooleate, P 0 E—P 0 E such as glyceryl monooleate.
  • POE sorbin ester such as polyoxyethylene (POE) sorbin monooleate
  • sorbin ester such as sorbitan monooleate
  • P 0 E—P 0 E such as glyceryl monooleate.
  • Glycery Glycerin fatty acid esters such as glycerin fatty acid esters and glycerin monooleate;
  • POE Polymers such as monooleate; POE—alkyl ethers such as lauryl ether; POE—branched alkyl ethers such as POE—octyldodecyl ether; POE—branched alkyl ethers such as POE—nonylphenyl ether P 0 E—glycerol esters such as alkylphenyl ether and glycerol monoisostearate; POE such as POE—glycerol monoisostearate—polyglycerin fatty acid esters such as diglyceryl monostearate Nonionic surfactants, fatty acid soaps such as sodium and sodium salts of higher fatty acids such as stearic acid, higher alkyl sulfates such as sodium lauryl sulfate, and alkyls such as POE-triethanolamine lauryl sulfate Ether sulfate, LA N-acyl sarcosine salts such as royl
  • alcohols include lower alcohols such as ethyl alcohol, propyl alcohol, and isopropyl alcohol, glycerin, polyglycerin, trimethylolpropane, pentaerythritol, dipentyl erythritol, ethylene glycol, propylene glycol, polypropylene glycol, polypropylene glycol, and the like.
  • the same components as those exemplified as the desired components in the description of the humectant of the present invention can be given.
  • the thickening agent examples include natural polymer substances such as sodium alginate, xanthan gum, malomelo seed extract, tragacanth gum, starch, and semi-synthetic polymers such as methyl cellulose, hydroxyethyl cellulose, carboxymethyl cellulose, soluble starch, and cationized cellulose. Substances, synthetic high molecular substances such as carboxyvinyl polymer and polyvinyl alcohol.
  • antibacterial and antifungal agents examples include methyl p-oxybenzoate, ethyl p-oxybenzoate, dehydroacetic acid, salicylic acid, benzoic acid, sorbic acid, and benzalkonium chloride. Examples thereof include dibutylhydroxytoluene, butylhydroxyanitool, provyl gallate, and ascorbic acid.
  • Examples of the chelating agent include disodium edetate, ethanehydroxydiphosphate, pyrophosphate, hexametaphosphate, citrate, tartaric acid, and gluconic acid
  • examples of the pH adjuster include sodium hydroxide, Triethanolamine, cunic acid, sodium citrate, boric acid, borax, sodium monohydrogen phosphate and the like.
  • examples of the ultraviolet absorber include 2-hydroxy-4-methoxybenzophenone, octyldimethyl p-aminobenzoate, and ethylhexyl p-methoxycinnamate
  • examples of the ultraviolet scattering agent include titanium oxide, kaolin, and talc. No.
  • vitamins include, for example, vitamin A, vitamin B, vitamin C, biyumin D, vitamin E, vitamin F, vitamin, vitamin P, vitamin U, power lunitine, ferulic acid, hi-orizanol, herlipoic acid, Orotic acid and its derivatives include amino acids such as glycine, alanine, norin, oral isin, isoleucine, serine, threonine, fenylalanine, tyrosine, triptophan, cystine, cystine, methionine, proline, and hydroxy. Examples include proline, aspartic acid, glutamic acid, arginine, histidine, lysine and derivatives thereof.
  • the medicament of the present invention contains the moisturizing fraction separated from the parotid gland secretion of the mammal as one component of the medicinal external preparation base.
  • the drug of the present invention can improve the function of retaining water on the skin surface by applying it to the skin as an external preparation.
  • urea-based compounds which are moisturizing components added to external preparations for pharmaceuticals, may cause skin crispness, pain, erythema, itching, burning, desquamation, hypersensitivity, etc. It can also occasionally cause eczema, skin cracks, rarely swelling and dryness.
  • the medicament of the present invention does not have the drawbacks of the above-mentioned urea compounds, and is effective for improving cracks, scabs and other diseases caused by dry skin, rough skin and dry skin. In addition, it improves the water retention function of the skin surface, which is advantageous in bringing out the therapeutic effect of the drug.
  • the amount of the moisturizing fraction (dry state) according to the present invention contained in the pharmaceutical of the present invention depends on the purpose of use, dosage form, presence or absence of other moisturizing components, and the like. It is in the range of 0.001-2% by weight based on the total amount of the chemical. If the content is less than 0.001% by weight, the moisturizing function may not be sufficiently exerted. If the content exceeds 2% by weight, no improvement in the effect is recognized for the amount, and economical efficiency is obtained. Disadvantaged. In consideration of the moisturizing effect and economy, the preferred content is in the range of 0.05 to 0.2% by weight.
  • the base used in the pharmaceutical product of the present invention can be appropriately selected according to the desired dosage form of the pharmaceutical from the various components conventionally used as the base in external preparations of various dosage forms. You can choose.
  • the dosage form of the drug of the present invention is not particularly limited, and includes, for example, creams, ointments, mouthwashes, etc., regardless of whether the base is hydrophilic or lipophilic.
  • the moisturizing fraction according to the present invention can be blended.
  • the drug that can be used in the pharmaceutical of the present invention is not particularly limited, and any drug that can be administered in the form of an external preparation can be used.
  • the medicine may contain, as desired, for example, each of the components exemplified as the desired components in the description of the cosmetic, an anti-inflammatory agent, an antipruritic agent, a bactericidal disinfectant, a feel improving agent, a hormonal agent and the like. Can be done.
  • an anti-inflammatory agent an antipruritic agent
  • a bactericidal disinfectant a feel improving agent
  • a hormonal agent a hormonal agent and the like.
  • the parotid gland secretion was collected, and 0.15% by weight of methyl paraoxybenzoate was added as a preservative and stored in a cool place.
  • the parotid gland secretion was filtered through filter paper No. 2 (Too Roshi Kaisha, Ltd.), and 100 liters thereof were stirred at 5 to 10 ° C in an extractor with a cooling device. While adding twice the amount (v / v) of acetone (acetone concentration: 66.6% (v / v)), a precipitate was formed, and the precipitate was collected.
  • the resulting precipitate was dehydrated by adding an appropriate amount of acetone, and the acetone was removed by filtration to obtain an acetone-dehydrated cake.
  • Test Example 1 Skin effect test A (sensory test)
  • test results were as follows: 8 subjects answered that the skin was “smooth” and “bulkyness” had disappeared, and 2 subjects had answered that “bulkyness” had disappeared. No subjects responded.
  • the moisturizing fraction according to the present invention has a low concentration of 0.01% by weight, Also, it can be seen that the powder has an excellent moisturizing function.
  • Test Example 2 Skin effect test B (sensory test)
  • the moisturizing fraction 5 O mg was kneaded into 500 g of white petrolatum to prepare an ointment treated with 0.01% by weight.
  • test results were as follows: 9 subjects answered that their skin was “smooth” and “bulkyness” had disappeared, and 1 subject had answered that “bulkyness” had disappeared. No subjects responded.
  • the cosmetic containing the moisturizing fraction according to the present invention gives moisture to the oil-deprived skin.
  • a test for evaluating the rough skin improving effect of the cosmetic containing the moisturizing fraction obtained in Production Example 1 above was performed in the following manner.
  • An ointment prepared by mixing the moisturizing fraction of 5 O mg in 500 g of white petrolatum and treating with 0.01% by weight was prepared.
  • test results were 8 valid, 2 valid, and 0 invalid.
  • the cosmetic containing the moisturizing fraction according to the present invention has the effect of improving rough skin and renewing the moisturizing function of the skin.
  • Test example 4 Cleaning resistance test
  • test results were as follows: 3 subjects who answered that the feeling of "smooth” did not disappear even after washing 5 times or more, 5 subjects who answered that the feeling of “smooth” did not disappear after 4 times, etc. None of the subjects answered one time and one subject answered twice, and none of the subjects answered that the feeling of “smoothness” disappeared by one washing.
  • the cosmetic containing the moisturizing fraction according to the present invention does not lose its moisturizing film even after several washings, and retains its moisturizing properties.
  • the lotion having the above-mentioned formula containing the moisturizing fraction according to the present invention moisturizes the skin and creates a "smooth" skin, and the following formulation examples make cosmetics extremely good on the skin. did.
  • 1,3-butylene glycol 3 0 squalane 2 0 stearic acid 2 0 liquid paraffin 6 0 sorbitan monostearate 1 5 polyoxyethylene (20) sorbitan monostearate 2 0 butyl parahydroxybenzoate 0 05 paraoxy Methyl benzoate 0 1 Moisturizing fraction from parotid gland secretion 0 01 Fragrance
  • Liquid paraffin 10 0 SENOLUNO 2 0 Cholesterin 0 5 Monoglyceride 1 0 Polyoxyethylene (6) sorbitan monohydrate 5.0 Moisturizing fraction derived from parotid gland secretion 0.02 Purified water Residue
  • the above-mentioned hair base conditioning water containing the moisturizing fraction according to the present invention takes a few milliliters after shampooing, and when applied to hair and scalp, the hair becomes ⁇ smooth '' and the hair styling material can be used thereafter.
  • the combing was greatly improved. It also moisturized the scalp, enhanced the water retention function, and improved drying.
  • Purified water Residue Formulation example 11 1 Skin cream
  • the humectant, cosmetic and pharmaceutical product of the present invention contain a moisturizing fraction derived from a parotid gland secretion of a mammal as an active ingredient, and the moisturizing fraction has a very small amount of a moisturizing function. It can exert and enhance the moisture retention function of the skin.
  • the moisturizer, cosmetics and pharmaceuticals of the present invention can make the skin “moist” and improve the slip of the hair without causing discomfort such as "stickiness". Furthermore, the moisturizing function is highly durable, and even after several washings with water or hot water, the moisturizing film on the skin surface does not fall off.
  • the moisturizing fraction into an external preparation for medicine, the function of retaining moisture on the skin surface is improved, and it works advantageously to bring out the medicinal properties of the medicine.

Abstract

A humectant containing as the active ingredient a fraction of the parotid secretion of a mammal which precipitates from a water-miscible organic solvent at a concentration of 60 % (v/v) or higher; a method of moisturizing the skin, hair, and scalp by applying this humectant thereto; a cosmetic preparation comprising a cosmetic base and the above fraction; and a medicine comprising a base for medicinal external preparations and the above fraction. The humectant fraction derived from the parotid secretion of a mammal, used in the humectant, cosmetic preparation, and medicine, can perform its moisturizing function even in an extremely small amount to not only enhance the moisture-retaining function of the skin but improve the slip properties of the hair. Furthermore, it is safe for the human body.

Description

明 細 書 - 保湿剤、 それを含む化粧料および医薬品 技術分野  Description-Moisturizer, cosmetics and pharmaceuticals containing it
本発明は、 新規な保湿剤、 それを用いた保湿方法及び該保湿剤を含む化粧料と 医薬品に関する。 さらに詳しくは、 本発明は、 保湿性に優れ、 かつ保湿機能の持 続性が高く、 皮膚や頭髪にしっとり感と滑らかさを付与しうる上、 人体に対して 安全性の葛い新規な保湿剤、 この保湿剤を用いて皮膚や頭髪を保湿する方法、 並 びに該保湿剤を含有する化粧料および医薬品に関するものである。 景技  TECHNICAL FIELD The present invention relates to a novel humectant, a humidifying method using the humectant, and cosmetics and pharmaceuticals containing the humectant. More specifically, the present invention is a novel moisturizer that has excellent moisturizing properties, has high durability of moisturizing function, can impart moist feeling and smoothness to skin and hair, and is safe for the human body. The present invention relates to a method for moisturizing skin and hair using the humectant, and to cosmetics and pharmaceuticals containing the humectant. Skill
皮膚化粧料は、 適度の水分と油分を皮膚に与えて皮膚の乾燥を防止する目的で、 親水性の皮膚保湿剤と油性の皮膚柔軟剤とを配合して調製されるのが一般的であ る。  Skin cosmetics are generally prepared by blending a hydrophilic skin moisturizer and an oily emollient to give the skin adequate moisture and oil to prevent the skin from drying out. You.
上記親水性の皮膚保湿剤としては、 従来、 ポリエチレングリコール、 ポリプロ ビレングリコールなどのポリエーテル類や、 グリセリン、 ソルビトールなどが利 用されてきたが、 近年、 天然保湿因子 [Natural Moisturizing Factor ( NM F )] と呼ばれるアミノ酸類、 ピロリ ドンカルボン酸ナトリウム、 尿素、 乳酸ナト リウムなどや、 ヒアルロン酸ナトリウム、 唾液腺ムチンなどの天然の高分子化合 物が使用されるようになってきた。  Conventionally, polyethers such as polyethylene glycol and polypropylene glycol, glycerin, and sorbitol have been used as the hydrophilic skin moisturizer, but in recent years, natural moisturizing factor (NMF) has been used. Amino acids, sodium pyrrolidonecarboxylate, urea, sodium lactate, etc., and natural high molecular weight compounds such as sodium hyaluronate and salivary gland mucin have been used.
しかしながら、 従来、 使用されていたポリエーテル類や、 グリセリン、 ソルビ トールなどの保湿剤は皮膚科学的に異質であるという欠点を有しており、 また、 皮膚の最外層である角質層の水分を吸収してしまい、 むしろ皮膚の水分を失わせ る原因になることがあるし、 近年使用されるようになった N M F類は天然物由来 物質であるが、 使用感が悪かったり、 保湿効果に劣ったりするなどの欠点がある。 これに対し、 ヒアルロン酸ナトリウムは、 現在数多くの化粧品に配合され、 そ の 0 . 0 2〜0 . 1重量%程度の濃度範囲で皮膚に 「しっとり感」 と 「滑らか さ」 を与えることから、 その有用性が高く評価されている。 また、 安全性試験に おいては、 2〜 3重量%の濃度範囲でも実験動物による局所刺激性、 -感作性など は認められず、 また、 ヒト貼布試験では、 1重量%の濃度においても安全である ことが確認されている。 However, conventionally used moisturizers such as polyethers, glycerin, and sorbitol have the drawback of being dermatologically heterogeneous, and also have the disadvantage of removing water from the outermost layer of the skin, the stratum corneum. NMFs may be absorbed and rather cause skin to lose moisture.NMFs, which have been used in recent years, are substances derived from natural products, but they have a poor feeling on use and have a poor moisturizing effect. There are drawbacks such as On the other hand, sodium hyaluronate is currently used in many cosmetics and gives a skin a "moist feeling" and "smoothness" in a concentration range of about 0.02 to 0.1% by weight. Its usefulness has been highly evaluated. In addition, for safety testing In the range of 2 to 3% by weight, no local irritation or sensitization was observed in laboratory animals, and in human patch tests, it was safe even at a concentration of 1% by weight. Has been confirmed.
唾液腺ムチンもまた、 優れた保湿作用を有し、 皮膚に与える 「しっとり感」 と 「滑らかさ」 は、 ヒアルロン酸ナトリウムよりも優れていると評価されている。 唾液腺ムチンは、 保湿作用および乳化作用を有し、 人体に対する安全性も高いこ とが確認されており、 かなり理想的な保湿剤であるといえる。 唾液腺ムチンは、 哺乳動物、 例えば、 ゥシ、 ゥマ、 ブ夕、 ヒヅジ等の唾液腺、 すなわち顎下腺、 耳 下腺および舌下腺等で生合成され、 分泌される糖タンパク質である。 動物の種類 によって固有の粘稠性を有し、 シアル酸を大量に含む分子量約 1 0万〜 1 0 0万 の巨大分子として得られるものである。  Salivary gland mucins also have an excellent moisturizing effect, and their "moistness" and "smoothness" on the skin are evaluated as being superior to sodium hyaluronate. It has been confirmed that salivary gland mucin has moisturizing and emulsifying effects and is highly safe for the human body, and can be said to be a fairly ideal moisturizer. Salivary gland mucin is a glycoprotein that is biosynthesized and secreted by the salivary glands of mammals, for example, pests, pomas, bushes, and sheep, such as the submandibular, parotid, and sublingual glands. It has an inherent viscosity depending on the type of animal and is obtained as a macromolecule containing a large amount of sialic acid and having a molecular weight of about 100,000 to 100,000.
このような天然の高分子化合物の優れた特性に着目し、 近年化粧品、 医薬品等 (特に皮膚外用剤) の保湿剤として、 また食品、 化粧品、 医薬品、 医薬部外品、 トイレタリー等の各種産業分野において、 乳化剤としての利用の研究が進められ 一部実用化されている。 しかしながら、 これら天然の高分子化合物からなる保湿 剤は、 その性能が十分に発揮される量で用いるには製造コス卜がかかり過ぎる上、 毛髪に対する化粧料への利用は、 その効果が期待できないという欠点がある。 さらにヒアルロン酸ナトリウムゃ唾液腺ムチンを含む化粧料では、 その使用感 は改善されるが、 両成分とも分解し易いため、 経時的に低分子化し、 保湿性およ び粘性が低下する。 また、 水や温湯による洗浄により簡単に保湿性皮膜が除去さ れてしまうという欠点を有している。  Focusing on the excellent properties of such natural polymer compounds, in recent years, as a moisturizer for cosmetics, pharmaceuticals, etc. (especially skin external preparations), and in various industrial fields such as foods, cosmetics, pharmaceuticals, quasi-drugs, and toiletries , Research on its use as an emulsifier has been promoted and some have been put into practical use. However, it is said that the humectant composed of these natural polymer compounds requires too much production cost to be used in an amount sufficient to exhibit its performance, and that its effect in hair cosmetics cannot be expected. There are drawbacks. In addition, cosmetics containing sodium hyaluronate and salivary gland mucin improve the feeling of use, but because both components are easily decomposed, the molecular weight decreases over time, and the moisturizing property and viscosity decrease. Another disadvantage is that the moisturizing film is easily removed by washing with water or hot water.
一方、 油性の皮膚柔軟剤としては、 流動パラフィンやワセリンなどが用いられ ているが、 これら皮膚柔軟剤を、 表皮からの正常な水分蒸散を阻害する程度まで 添加すると、 「ベとつき」 による違和感を与え、 皮膚保湿剤としての有用性に欠 ける。 発明の開示  On the other hand, liquid oils such as liquid paraffin and petrolatum are used as emollients, but when these emollients are added to such an extent that they prevent normal evaporation of water from the epidermis, unpleasant feeling due to stickiness And lacks usefulness as a skin moisturizer. Disclosure of the invention
このような事情のもとで、 本発明の第 1の目的は、 ( 1 )極めて微量で保湿性を 発揮し、 各種の化粧料基剤や医薬品外用剤基剤に配合可能である、 (2 )皮膚およ び頭髪に 「しっとり感」 と 「滑らかさ」 を与えることができる、 (3 )従来の油性 皮膚柔軟剤のような 「ベとつき」 、 「よれ」 などの違和感を与えない、 (4 )保湿 機能の持続性に優れる、 ( 5 )数回の水や温湯による洗浄によっても、 保湿性皮膜 が除去されることがない、 ( 6 )人体に対して安全性が高い、 などの特徴を有する 新規な保湿剤を提供することである。 Under such circumstances, the first object of the present invention is to (1) exert a moisturizing property in an extremely small amount, and can be blended into various cosmetic bases and bases for external preparations for pharmaceuticals. ) Skin and (3) It can give a moist feeling and "smoothness" to hair and hair. (3) It does not give a feeling of incongruity such as "stickiness" or "sharpness" like conventional oily emollients. (4) Moisturizing. (5) The moisturizing film is not removed even after washing with water or hot water several times, (6) It is highly safe for the human body. Is to provide a suitable humectant.
また、 第 2の目的は、 前記保湿剤を用いて、 皮膚や頭髪を保湿する方法を提供 することであり、 さらに、 第 3の目的は、 前記保湿剤を含有する化粧料および医 薬品を提供することである。  A second object is to provide a method for moisturizing skin and hair using the humectant, and a third object is to provide cosmetics and medicines containing the humectant. It is to be.
本発明者は、 前記目的を達成するために鋭意研究を重ねた結果、 多くの動物が 自分の体を舌で嘗めて毛繕いをし、 唾液が乾くと、 美しい、 滑らかなつやつやし た毛になること、 さらには、 傷口も舌で嘗めて潤いを与え、 .一乾燥を防ぎ、 傷の治 りを早めていることに着目し、 哺乳動物の耳下腺分泌液から、 ある種の方法で分 離した成分が、 (a )極めて微量で保湿機能を発揮するとともに、 人体に対して安 全である、 (b )粉末のままでも、 水に溶解して、 皮膚に塗布すると保湿機能を発 揮する、 (c )各種の化粧料基剤および医薬品外用剤基剤に配合して使用すること ができ、 例えば、 粉末のままカット綿や紙にまぶしても、 水溶液としても、 また、 クリーム、 ローション、 医薬品外用剤の基剤などに加えて使用しても皮膚の水分 保持機能を亢進させる特性を有している、 (d )皮膚への吸着性に優れ、 かつ皮膚 や頭髪に 「しっとり感」 、 「滑らかさ」 を与える一方、 「ベとつき」 や 「よれ」 等の違和感を全く与えず、 極自然な皮膚感触を与える、 (e )必要以上に皮膚の角 質層から水分を吸収することもなく、 従来の親水性保湿剤のような欠.点がない、 ( f )数回の水や温湯による洗浄にも耐え、 洗浄によっても皮膚表面の保湿性皮膜 が落ちることがなく、 皮膚の水分保持状態に変化を与えない、 など優れた特性を 有することを見出し、 この知見に基づいて本発明を完成するに至った。  The present inventors have conducted intensive studies to achieve the above object, and as a result, many animals lick their bodies with their tongues and groom, and when saliva dries, beautiful and smooth shiny hair is obtained. Focusing on the fact that the wound is moisturized with the tongue, preventing dryness and accelerating the healing of the wound, a certain method is used from the parotid gland secretion of mammals. The separated components are (a) extremely moist, and exhibit a moisturizing function, and are safe for the human body. (B) Even in powder form, they dissolve in water and apply to the skin to exert a moisturizing function. (C) It can be used by blending it with various cosmetic bases and bases for external preparations for medicines. Lotion, base for external medicines, etc. It has the property of enhancing the function of retaining moisture. (D) It has excellent adsorptivity to the skin and gives the skin and hair a "moist feeling" and "smoothness", while "sticky" and "shaky" (E) It does not absorb the moisture from the stratum corneum of the skin more than necessary, and lacks the points like a conventional hydrophilic moisturizer. (F) Withstands several times of washing with water or hot water, does not remove the moisturizing film on the skin surface even after washing, and does not change the moisture retention state of the skin. The present invention was completed based on this finding.
すなわち、 本発明は、  That is, the present invention
( 1 ) 哺乳動物の耳下腺分泌液 (parotid secretion) の水混和性有機溶剤の濃度 6 0 % ( v/v) 以上で沈殿する画分を有効成分として含有することを特徴とす る保湿剤、  (1) A moisturizer characterized by containing, as an active ingredient, a fraction that precipitates at a water-miscible organic solvent concentration of 60% (v / v) or higher in the parotid secretion of mammals. Agent,
( 2 ) 上記 ( 1 ) の保湿剤を皮膚に塗布することを特徴とする皮膚の保湿方法、 ( 3 ) 上記 ( 1 ) の保湿剤を、 頭髮または頭皮あるいはその両方に塗布すること を特徴とする頭髪 ·頭皮の保湿方法、 (2) A method for moisturizing the skin, comprising applying the humectant of (1) to the skin, (3) A moisturizing method for hair and scalp, which comprises applying the moisturizing agent of (1) to the hair or scalp or both.
( 4 ) 化粧料基剤と、 哺乳動物の耳下腺分泌液の水混和性有機溶剤の濃度 6 0 % ( v/v ) 以上で沈殿する画分とを含有することを特徴とする化粧料、  (4) A cosmetic comprising a cosmetic base and a fraction that precipitates at a water-miscible organic solvent concentration of 60% (v / v) or higher in the parotid gland secretion of a mammal. ,
および  and
( 5 ) 医薬品外用剤基剤の一成分として、 哺乳動物の耳下腺分泌液の水混和性有 機溶剤の濃度 6 0 % ( v/v ) 以上で沈殿する画分とを含有することを特徴とす る医薬品、  (5) As a component of the pharmaceutical external preparation base, a fraction precipitated at a water-miscible organic solvent concentration of 60% (v / v) or higher in the parotid gland secretion of mammals should be contained. Pharmaceutical products,
を提供するものである。 発明を実施するための最良の形態 Is provided. BEST MODE FOR CARRYING OUT THE INVENTION
本発明の保湿剤は、 哺乳動物の耳下腺分泌液に由来する物質を、 有効成分とし て含有するものであって、 上記哺乳動物としては、 特に制限はなく、 例えばゥシ、 ゥマ、 ブ夕、 ヒヅジなどが挙げられるが、 分泌液の採取の容易性、 採取量 (ゥシ では 1曰に約 5 0〜6 0リットル分泌される) 、 経済性等を考慮すると、 ゥシが 好ましい。  The humectant of the present invention contains, as an active ingredient, a substance derived from the parotid fluid of a mammal, and the mammal is not particularly limited. Although it is preferable to take the secretion fluid into consideration, such as ease of collection, amount of secretion (1 to 50 to 60 liters is secreted in one case), economy, etc. .
哺乳動物の口腔内に分泌される唾液 (分泌液が口腔内へ流れ出たもの) は、 耳 下腺、 顎下腺および舌下腺からの分泌液の混合物である。 その分泌量に対するそ れそれの唾液腺分泌液の割合は、 およそ耳下腺 7 0重量%、 顎下腺 5重量%、 舌 下腺 2 5重量%である。 本発明において用いる哺乳動物の分泌液は、 耳下腺から 分泌されるものに限定され、 他の唾液分泌腺である顎下腺および舌下腺から分泌 される分泌液が実質上混入していないものである。 混合物としての唾液には粘液 性成分と漿液性成分が含まれているが、 耳下腺からの分泌液である耳下腺分泌液 は、 漿液性であり、 ほとんどが水分であることが知られている。 現在まで、 「唾 液」 に関しては混合物としての全唾液のみが研究対象とされ、 上記の 3つの腺そ れそれの分泌液についての研究はほとんどなされていなかった。 本発明者は、 そ れそれの唾液分泌腺から得られる分泌液について検討を行い、 耳下腺分泌液中に 極めて優れた保湿機能を有する成分が含まれていることを見出したのである。 哺乳動物の耳下腺分泌液を採取するには、 動物の耳下の皮虜を切開し、 口腔表 皮近くで耳下腺導管を露出させ、 力ニューレの先端を挿入できるように耳下腺導 管をわずかに切開する。 皮膚の切開部から力二ュ一レを導き、 耳下腺導管の切開 部から耳下腺側に向けて力ニューレ先端を差し込む。 皮膚の切開部傷口はカニュ ーレを粘着テープで固定しつつ塞ぐ。 力ニューレの反対側の先端に受器を置き、 自然に流れ落ちる耳下腺分泌液を採取すればよい。 Saliva secreted into the mouth of mammals (secreted fluid flowing into the mouth) is a mixture of secretions from the parotid, submandibular and sublingual glands. The ratio of salivary gland secretion to its secretion is about 70% by weight of parotid gland, 5% by weight of submandibular gland, and 25% by weight of sublingual gland. The secretion of the mammal used in the present invention is limited to that secreted from the parotid gland, and is substantially free of the secretion secreted from other salivary glands, the submandibular gland and the sublingual gland Things. Saliva as a mixture contains mucous and serous components, but the parotid gland secretion, which is the secretion from the parotid gland, is known to be serous and mostly water. ing. To date, only "all saliva" as a mixture has been studied for "saliva", and little has been done on the secretions of the three glands described above. The present inventors have studied the secretions obtained from the salivary glands and found out that the parotid secretions contained a component having an extremely excellent moisturizing function. To collect the parotid gland secretion of a mammal, an incision is made on the skin below the animal's parotid and the oral surface Expose the parotid gland duct near the skin and make a small incision in the parotid gland duct so that the tip of the forcenula can be inserted. Guide the force through the incision in the skin, and insert the tip of the force neuron from the incision in the parotid duct toward the parotid gland. The incision wound on the skin is closed while the cannula is fixed with adhesive tape. A receiver can be placed on the opposite end of the force neuron to collect the parotid gland fluid that flows off naturally.
採取された耳下腺分泌液は、 保管する場合、 防腐剤を添加して冷所に保管する のがよい。 ここで、 添加する防腐剤としては通常の防腐剤、 例えば安息香酸類、 パラォキシ安息香酸類、 デヒドロ酢酸類、 ソルビン酸類、 フエノール類、 アルコ ール類、ソ、ロゲン類、 グルタールアルデヒド類、 ?—プロビオラクトン類等、 ま たはこれらの混合物が挙げられる。 好ましくは無臭のものかまたは臭いがあって も後工程で容易に除けるものが望ましく、 特に、 パラォキシ—安息香酸類が好適で ある。  When storing the collected parotid secretions, it is better to add preservatives and store them in a cool place. Here, the preservatives to be added include ordinary preservatives, for example, benzoic acids, paraoxybenzoic acids, dehydroacetic acids, sorbic acids, phenols, alcohols, sodium, rogens, glutaraldehydes,? -Probio Lactones and the like, or a mixture thereof. Preferably, it is odorless or one which can easily be removed in the subsequent step even if it has an odor, and paraoxy-benzoic acids are particularly preferred.
本発明の保湿剤は、 哺乳動物の耳下腺分泌液を水混和性有機溶剤と混合して、 有機溶剤濃度 6 0 % ( v/v ) 以上で沈殿する画分 (以下、 保湿性画分と称する ことがある) を有効成分として含有するものである。 上記有機溶剤濃度 6 0 % ( v/v) 以上とする理由は、 次のとおりである。 有機溶剤を耳下腺分泌液に添 加していくと、 耳下腺分泌液中の保湿性成分の溶解度が低下し、 沈殿生成が起こ り始める。 有効な有機溶剤添加量はこの沈殿を実質的に回収できるときの量とし て規定され、 それが、 およそ 6 0 % ( v/v ) 以上となる。 したがって、 有機溶 剤の種類によってこの添加量は若干異なるが、 本発明の場合、 有機溶剤の添加量 が 6 0 % ( v/v) 未満では、 実用的な沈殿生成が期待できない。 .  The humectant of the present invention is obtained by mixing a mammalian parotid gland secretion with a water-miscible organic solvent, and a fraction that precipitates at an organic solvent concentration of 60% (v / v) or more (hereinafter, the humectant fraction). ) May be contained as an active ingredient. The reason for setting the organic solvent concentration to 60% (v / v) or more is as follows. As the organic solvent is added to the parotid gland secretion, the solubility of the moisturizing components in the parotid gland secretion decreases and sedimentation begins to occur. The effective amount of organic solvent added is defined as the amount at which this precipitate can be substantially recovered, which is about 60% (v / v) or more. Therefore, the amount of addition varies slightly depending on the type of organic solvent, but in the case of the present invention, if the amount of addition of the organic solvent is less than 60% (v / v), practical precipitation cannot be expected. .
このように、 有機溶剤の濃度は 6 0 % ( v/v ) 以上であればいくら高くても 特に制限はないが、 生成する沈殿の量及び過剰な有機溶剤の使用による経済性を 考えれば、 有機溶剤の濃度は 6 3 ~ 8 0 % ( v/v ) 程度が好ましく、 さらに好 ましくは 6 5〜7 5 % ( v/v) 程度の濃度である。  As described above, the concentration of the organic solvent is not particularly limited as long as it is 60% (v / v) or more, but considering the amount of formed precipitate and the economics of using an excessive amount of the organic solvent, The concentration of the organic solvent is preferably about 63 to 80% (v / v), and more preferably about 65 to 75% (v / v).
前記のようにして採取された耳下腺分泌液をそのまま、 または濾過後、 抽出機 中に入れ、 好ましくは冷却下 (0〜1 5 °C程度) で攪拌しながら水混和性有機溶 剤を加え、 有機溶剤濃度が 6 0 % ( v/v) 以上で沈殿する画分を回収する。 得 られた保湿性画分は、 そのまま用いてもよいが、 脱水、 乾燥処理し、 粉末として 用いるのが有利である。 脱水の方法としては、 得られた画分にさらに水混和性有 機溶剤を加える方法がある。 また、 乾燥方法としては、 通気法、 減圧法等があり、 また、 これらの方法を組み合わせることもできるし、 さらに加熱を加えることも 可能である。 The parotid gland secretion collected as described above, or after filtration, is put into an extractor, and the water-miscible organic solvent is stirred preferably under cooling (about 0 to 15 ° C). In addition, collect the fraction that precipitates when the organic solvent concentration is 60% (v / v) or more. The obtained moisturizing fraction may be used as it is, but it is dehydrated and dried to obtain a powder. It is advantageous to use it. As a method of dehydration, there is a method of further adding a water-miscible organic solvent to the obtained fraction. As a drying method, there are an aeration method, a decompression method, and the like. These methods can be combined, and further heating can be applied.
ここで用いる水混和性有機溶剤としては、 例えばアセトン、 エタノール、 メ夕 ノール及びイソプロパノール等が挙げられ、 これらは単独で用いてもよいし、 2 種以上を混合して用いてもよいが、 アセトンが特に好適である。  Examples of the water-miscible organic solvent used here include acetone, ethanol, methanol, and isopropanol. These may be used alone or in combination of two or more. Is particularly preferred.
この保湿性画分の収率は、 耳下腺分泌液を採取する動物の健康状態などにより 左右されるが、 一般的には、 乾燥画分として、 耳下腺分泌液に対し、 0 . 1 5〜 0 . 7重量%程度である。 また、 この乾燥保湿性画分中の窒素含有量およびタン パク質含有量は、 動物の健康状態などにより左右されるが、 一般的には、 それそ れ 0 . 0 5〜0 . 4重量%および 0 . 4 ~ 3重量%の範囲である。  The yield of the moisturizing fraction depends on the health of the animal from which the parotid gland secretion is collected, but is generally 0.1% as a dry fraction relative to the parotid gland secretion. It is about 5 to 0.7% by weight. The nitrogen content and protein content in the dry and moisturizing fraction depend on animal health and the like, but are generally in the range of 0.05 to 0.4% by weight. And 0.4 to 3% by weight.
なお、 該保湿性画分の保湿機能を有する物質はまだ特定されておらず、 単一物 質とは限らないが、 窒素含有量およびタンパク質含有量から、 ヒアルロン酸等の ムコ多糖類や唾液腺ムチン等とは異なる物質であると考えられる。  The substance having a moisturizing function of the moisturizing fraction has not yet been identified and is not necessarily a single substance. However, based on the nitrogen content and protein content, mucopolysaccharides such as hyaluronic acid and salivary gland mucin It is considered to be a substance different from the above.
このようにして、 哺乳動物の耳下腺分泌液から分離された保湿性画分は、 以下 に示すような特性を有している。  Thus, the moisturizing fraction separated from the parotid gland secretion of the mammal has the following properties.
( 1 ) 「ベとつき」 、 「よれ」 等の不快な違和感を与えず、 皮膚や頭髪に 「しつ とり感」 と 「滑らかさ」 を与えることができる。  (1) It can give the skin and hair a feeling of firmness and smoothness without giving any unpleasant discomfort such as "stickiness" and "sharpness".
( 2 ) 皮膚細胞の働きを活発化させ、 皮膚の柔軟性、 弾力性を増し、 皮膚を健康 に保つと共に、 皮膚に若さと艷を与えることができる。  (2) It activates the action of skin cells, increases the flexibility and elasticity of the skin, keeps the skin healthy and gives the skin a youthful and shiny look.
( 3 ) 粉末のままでも、 単に水に溶解しただけでも、 皮膚に対する保湿機能を発 揮するが、 化粧料や医薬品外用剤に配合すると、 それらの機能との相乗効果によ りさらに優れた保湿機能を発揮することができる。  (3) Even when powdered or simply dissolved in water, it exerts a moisturizing function on the skin, but when it is added to cosmetics or external preparations for pharmaceuticals, the synergistic effect with these functions further enhances moisturizing. Functions can be demonstrated.
( 4 ) 保湿機能の持続性が高いため、 従来の化粧料のように一日に何度も繰り返 し塗布し直す必要がない。  (4) Since the moisturizing function is highly persistent, there is no need to apply it repeatedly over and over again a day as with conventional cosmetics.
( 5 ) 数回の水や温湯による洗浄によっても、 皮膚の保湿性皮膜が落ちることが なく、 優れた保湿性は低下しない。  (5) Even after washing with water or hot water several times, the moisturizing film on the skin does not fall off, and the excellent moisturizing property does not decrease.
( 6 ) 大量に使用しても、 生理的機能の変調をきたす恐れもなく、 極めて安全で ある。 (6) Even if used in large quantities, there is no danger of modulating physiological functions and it is extremely safe is there.
( 7 ) 化粧品や医薬品外用剤に通常用いられる各種の成分との混和性がよく、 特 に混合される成分について制限はない。  (7) It has good miscibility with various components commonly used in cosmetics and external preparations for pharmaceuticals, and there are no particular restrictions on the components to be mixed.
本発明の保湿剤は、 前記保湿性画分を有効成分として含有するものであるが、 該保湿剤には、 所望に応じ、 従来公知の保湿性成分を含有していてもよい。 公知 の保湿性成分としては、 例えばポリエチレングリコ一ルゃポリプロピレングリコ ールなどのポリエーテル類、 グリセリン、 1, 3—ブチレングリコール、 プロビ レングリコール、 ソルビトールなどの多価アルコール類、 さらには NM F類、 具 体的には-アミノ酸、 尿素、 乳酸ナトリウム、 ビロリ ドンカルボン酸ナトリウムや、 ヒアルロン酸、 コンドロイチン硫酸などのムコ多糖類、 コラーゲンやエラスチン などのタンパク質などが挙げられる。  Although the humectant of the present invention contains the humectant fraction as an active ingredient, the humectant may contain a conventionally known humectant component, if desired. Known moisturizing components include, for example, polyethers such as polyethylene glycol and polypropylene glycol, polyhydric alcohols such as glycerin, 1,3-butylene glycol, propylene glycol, and sorbitol, and NMFs. Specific examples thereof include -amino acids, urea, sodium lactate, sodium borolidone carboxylate, mucopolysaccharides such as hyaluronic acid and chondroitin sulfate, and proteins such as collagen and elastin.
次に、 本発明の保湿方法について説明する。 本発明の保湿方法は、 二つの態様 があって、 一つは、 前記本発明の保湿剤を皮膚に塗布し、 皮膚を保湿する方法で あり、 これにより、 皮膚に 「しっとり感」 と 「滑らかさ」 が付与される。  Next, the moisturizing method of the present invention will be described. The moisturizing method of the present invention has two aspects. One is a method of applying the moisturizing agent of the present invention to the skin to moisturize the skin, whereby the skin has a “moist feeling” and “smoothness”. Is given.
もう一つは、 前記本発明の保湿剤を、 頭髪または頭皮あるいはその両方に塗布 し、 それらを保湿する方法であり、 これにより、 頭髪の表面状態が改善されて、 頭髪表面の滑り (いわゆる櫛どおり) がよくなり、 整髪料の乗りがよくなるとと もに、 頭皮の乾燥が改善され、 かゆみ、 ふけが抑えられる。  The other is a method of applying the humectant of the present invention to the hair and / or scalp and moisturizing them, whereby the surface condition of the hair is improved and the slip on the hair surface (so-called comb) As expected), hair dressing is improved and drying of the scalp is improved, and itching and dandruff are suppressed.
これらの方法において、 塗布する際の保湿剤の形態については特に制限はなく、 例えば後述の各種形態の化粧料や、 各種剤型の医薬品外用剤として、 保湿剤を用 いることができる。  In these methods, the form of the humectant at the time of application is not particularly limited, and for example, a humectant can be used as a cosmetic in various forms described below or as an external preparation in various forms.
次に、 本発明の化粧料および医薬品について説明する。  Next, the cosmetics and pharmaceuticals of the present invention will be described.
まず、 本発明の化粧料は、 化粧料基剤と、 前記の哺乳動物の耳下腺分泌液から 分離された保湿性画分とを含有するものである。  First, the cosmetic of the present invention contains a cosmetic base and the moisturizing fraction separated from the above-mentioned mammalian parotid secretion.
本発明の化粧料に含有される保湿性画分 (乾燥状態) の量は、 化粧料の形態や 他の保湿成分の添加の有無などにもよるが、 通常、 化粧料全量に基づき 0 . 0 0 1 ~ 2重量%である。 この含有量が 0 . 0 0 1重量%未満では保湿機能が充分に 発揮されないおそれがあるし、 2重量%を超えるとその量の割には効果の向上が 認められず、 むしろ経済的に不利となる。 保湿効果および経済性などを考慮する と、 好ましい含有量は、 0 . 0 0 5〜0 . 2重量%の範囲である。 - 本発明の化粧料において用いられる基剤としては特に制限はなく、 従来各種形 態の化粧料において、 基剤として慣用されている各種成分の中から、 化粧料の所 望形態に応じて適宜選択することができる。 The amount of the moisturizing fraction (dry state) contained in the cosmetic of the present invention depends on the form of the cosmetic and the presence or absence of other moisturizing components, but is usually 0.0 based on the total amount of the cosmetic. 0 to 2% by weight. If the content is less than 0.001% by weight, the moisturizing function may not be sufficiently exhibited, and if it exceeds 2% by weight, no improvement in the effect is recognized for the amount, and it is economically disadvantageous. Becomes Consider the moisturizing effect and economy The preferred content is in the range of 0.05 to 0.2% by weight. -The base used in the cosmetic of the present invention is not particularly limited, and is appropriately selected according to the desired form of the cosmetic from various components conventionally used as the base in cosmetics of various forms. You can choose.
本発明の化粧料の形態は、 特に限定されないが、 例えば化粧水、 乳液、 クリー ム類、 パック剤、 ローション、 口紅、 ファンデーション、 皮膚洗浄剤等の皮膚化 粧料、 毛髪基礎調整水、 ヘアリンス、 ヘア一トニック、 ヘアークリーム、 ヘア一 ローション等の毛髪化粧料が挙げられ、 その基剤が水性のものでも、 油性のもの でも該保湿性画分は配合可能である。  Although the form of the cosmetic of the present invention is not particularly limited, for example, skin cosmetics such as lotion, milky lotion, creams, packs, lotions, lipsticks, foundations, skin cleansers, etc., hair conditioner, hair rinse, Hair cosmetics such as hair tonics, hair creams, and hair lotions can be mentioned, and the moisturizing fraction can be blended whether the base is aqueous or oily.
皮膚化粧料基剤に、 前記の本発明に係る保湿性画分を配合すると、 上記化粧料 基剤が元々有している保湿機能との相乗効果により、 さらに優れた保湿機能を発 揮することができる。  When the moisturizing fraction according to the present invention is blended with the skin cosmetic base, a more excellent moisturizing function is exerted due to a synergistic effect with the moisturizing function originally possessed by the cosmetic base. Can be.
また、 毛髪化粧料基剤に該保湿性画分を配合した毛髪化粧料は、 頭髪および頭 皮を健やかに保つ効果に優れており、 例えば、 洗髪後の頭髪および頭皮に塗布す ると、 頭髪の表面状態を改善して頭髪表面の滑り (いわゆる櫛どおり) がよくな り、 毛髪化粧料の乗りがよくなる。 さらに頭皮の乾燥を改善し、 かゆみ、 ふけを 抑えることができる。  In addition, a hair cosmetic in which the moisturizing fraction is blended with a hair cosmetic base has an excellent effect of keeping the hair and the scalp healthy. For example, when applied to the hair and the scalp after washing the hair, the hair By improving the surface condition of the hair, the slip on the hair surface (so-called comb-like) is improved and the riding of hair cosmetics is improved. It can also improve scalp drying and reduce itching and dandruff.
本発明の化粧料には、 所望に応じ、 従来化粧料に慣用されている各種成分、 例 えば油分、 界面活性剤、 乳化剤、 アルコール、 他の保湿成分、 増粘剤、 防腐剤 · 防菌防黴剤、 酸化防止剤、 キレート剤、 p H調整剤、 紫外線吸収剤、 紫外線散乱 剤、 顔料、 色素、 香料、 ビタミン類、 アミノ酸類、 水などを配合することができ る o  The cosmetic of the present invention may contain, if desired, various components conventionally used in cosmetics, for example, oils, surfactants, emulsifiers, alcohols, other moisturizing components, thickeners, preservatives, and antibacterial protection. Can contain fungicides, antioxidants, chelating agents, pH adjusters, ultraviolet absorbers, ultraviolet scattering agents, pigments, dyes, fragrances, vitamins, amino acids, water, etc.
前記油分としては、 例えばヒマシ油、 ォリーブ油、 ホホバ油、 椿油などの液体 油脂、 硬化ヒマシ油などの固体油脂、 ラノリン、 鯨ロウ、 蜜ロウ、 カルナウバロ ゥ、 キャンデリラロウなどのロウ類、 スクヮラン、 ワセリン、 流動パラフィン、 セリシン、 パラフィンなどの炭化水素類などが挙げられる。  Examples of the oil component include liquid oils such as castor oil, olive oil, jojoba oil, camellia oil, solid oils such as hardened castor oil, lanolin, whale wax, beeswax, carnauba wax, waxes such as candelilla wax, squalane, Examples include hydrocarbons such as petrolatum, liquid paraffin, sericin, and paraffin.
界面活性剤としては、 例えばポリオキシエチレン (P O E ) ソルビ夕ンモノォ レエートなどの P O Eソルビ夕ンエステル、 ソルビタンモノォレエートなどのソ ルビ夕ンエステル、 P 0 E—グリセリルモノォレエートなどの P 0 E—グリセリ ン脂肪酸エステル、 グリセリンモノォレエートなどのグリセリン脂肪酸エステル、Examples of the surfactant include POE sorbin ester such as polyoxyethylene (POE) sorbin monooleate, sorbin ester such as sorbitan monooleate, P 0 E—P 0 E such as glyceryl monooleate. —Glycery Glycerin fatty acid esters such as glycerin fatty acid esters and glycerin monooleate;
P O E—モノォレエートなどの P O E—脂肪酸エステル、 P O E—ラウリルエー テルなどの P O E—アルキルエーテル、 P O E—ォクチルドデシルェ一テルなど の P 0 E—分岐アルキルエーテル、 P 0 E—ノニルフェニルェ一テルなどの P 0 E—アルキルフエ二ルェ一テル、 グリセロールモノイソステアレートなどのグリ セロールエステル、 P O E—グリセロールモノイソステアレートなどの P O E— グリセロールエステル、 ジグリセリルモノステアレートなどのポリグリセリン脂 肪酸エステルなどの非イオン性界面活性剤、 ステアリン酸などの高級脂肪酸のナ トリゥム塩や力リゥム塩などの脂肪酸石ケン、 ラゥリル硫酸ナトリゥムなどの高 級アルキル硫酸エステル塩、 P O E—ラウリル硫酸トリエタノールァミンなどの アルキルエーテル硫酸エステル、 ラウロイルサルコシンナトリゥムなどの N—ァ シルサルコシン酸塩、 N—ミリストイルー N—メチルタウリンナトリゥムなどの 高級脂肪酸アミ ドスルホン酸塩、 リニアドデシルベンゼンスルホン酸ナトリウム などのアルキルベンゼンスルホン酸ナトリゥム、 N—ステアロイルグル夕ミン酸 ジナトリゥムなどの N—ァシルグル夕ミン酸塩などの陰イオン性界面活性剤、 ァ ルキルアミン塩、 P O E—アルキルアミン塩、 ポリアミン脂肪酸誘導体、 アルキ ルビリジニゥム塩、 アルキル四級アンモニゥム塩、 アルキルジメチルベンジルァ ンモニゥム塩、 アルキルイソキノリニゥム塩、 ジアルキルモルホリニゥム塩、 塩 化べンゼトニゥムなどの陽イオン性界面活性剤、 ベ夕イン系、 イミダゾリン系、 アミンォキシド系などの両性界面活性剤などが挙げられる。 POE—Polyesters such as monooleate; POE—alkyl ethers such as lauryl ether; POE—branched alkyl ethers such as POE—octyldodecyl ether; POE—branched alkyl ethers such as POE—nonylphenyl ether P 0 E—glycerol esters such as alkylphenyl ether and glycerol monoisostearate; POE such as POE—glycerol monoisostearate—polyglycerin fatty acid esters such as diglyceryl monostearate Nonionic surfactants, fatty acid soaps such as sodium and sodium salts of higher fatty acids such as stearic acid, higher alkyl sulfates such as sodium lauryl sulfate, and alkyls such as POE-triethanolamine lauryl sulfate Ether sulfate, LA N-acyl sarcosine salts such as roylsarcosine sodium, higher fatty acid amide sulfonates such as N-myristoyl-N-methyltaurine sodium, sodium alkylbenzenesulfonate such as sodium linear dodecylbenzenesulfonate, N-stearoyl Anionic surfactants such as N-acyl glutamate such as glutamate dinadium, alkylamine salts, POE-alkylamine salts, polyamine fatty acid derivatives, alkyl viridinium salts, alkyl quaternary ammonium salts, alkyldimethylbenzyl Cationic surfactants such as ammonium salts, alkyl isoquinolinium salts, dialkyl morpholinium salts, and benzenetonium chloride; and amphoteric surfactants such as benzoin-based, imidazoline-based, and amine oxide-based surfactants. It is below.
アルコールとしては、 例えばエチルアルコール、 プロビルアルコール、 イソプ 口ビルアルコールなどの低級アルコール、 グリセリン、 ポリグリセリン、 トリメ チロールプロパン、 ペン夕エリスリ トール、 ジペン夕エリスリトール、 エチレン グリコール、 プロピレングリコール、 ポリプロピレングリコ一ル、 1, 3—ブチ レングリコール、 1 , 4ーブチレングリコール、 さらにはグルコース、 マルトー ス、 マンノース、 ラクト一ス、 D—グルクロン酸、 ゥロン酸、 サッカロース、 D —マンニヅト、 D—ソルビット、 ソルビタン、 グルコノラクトン、 セルロース、 デンプン、 アルブチン、 グルコースリン酸エステルなどの単糖類、 多糖類及びこ れらの誘導体などが挙げられる。 他の保湿成分としては、 前記本発明の保湿剤の説明において、 所望成分として 例示したものと同じものを挙げることができる。 Examples of alcohols include lower alcohols such as ethyl alcohol, propyl alcohol, and isopropyl alcohol, glycerin, polyglycerin, trimethylolpropane, pentaerythritol, dipentyl erythritol, ethylene glycol, propylene glycol, polypropylene glycol, polypropylene glycol, and the like. 1,3-butylene glycol, 1,4-butylene glycol, and glucose, maltose, mannose, lactose, D-glucuronic acid, peronic acid, saccharose, D-mannite, D-sorbitol, sorbitan, glucono Monosaccharides such as lactone, cellulose, starch, arbutin, glucose phosphate and the like, polysaccharides and derivatives thereof are exemplified. As the other moisturizing components, the same components as those exemplified as the desired components in the description of the humectant of the present invention can be given.
増粘剤としては、 例えばアルギン酸ナトリウム、 キサンタンガム、 マロメロ種 子抽出物、 トラガントガム、 デンプンなどの天然高分子物質、 メチルセルロース、 ヒドロキシェチルセルロース、 カルボキシメチルセルロース、 可溶性デンプン、 カチオン化セルロースなどの半合成高分子物質、 カルボキシビ二ルポリマ一、 ポ リビニルアルコールなどの合成高分子物質などが挙げられる。  Examples of the thickening agent include natural polymer substances such as sodium alginate, xanthan gum, malomelo seed extract, tragacanth gum, starch, and semi-synthetic polymers such as methyl cellulose, hydroxyethyl cellulose, carboxymethyl cellulose, soluble starch, and cationized cellulose. Substances, synthetic high molecular substances such as carboxyvinyl polymer and polyvinyl alcohol.
防腐剤 '防菌防黴剤としては、 例えば p—ォキシ安息香酸メチル、 P—ォキシ 安息香酸ェチル、 デヒドロ酢酸、 サリチル酸、 安息香酸、 ソルビン酸、 塩化ベン ザルコニゥムなどが挙げられ、 酸化防止剤としては、 例えばジブチルヒドロキシ トルエン、 ブチルヒドロキシァ二ツール、 没食子酸プロビル、 ァスコルビン酸な どが挙げられる。  Preservatives Examples of the antibacterial and antifungal agents include methyl p-oxybenzoate, ethyl p-oxybenzoate, dehydroacetic acid, salicylic acid, benzoic acid, sorbic acid, and benzalkonium chloride. Examples thereof include dibutylhydroxytoluene, butylhydroxyanitool, provyl gallate, and ascorbic acid.
キレート剤としては、 例えばェデト酸ニナトリウム、 エタンヒドロキシジホス フェート、 ピロリン酸塩、 へキサメタリン酸塩、 クェン酸、 酒石酸、 グルコン酸 などが、 p H調整剤としては、 例えば水酸ィ匕ナトリウム、 トリエタノールァミン、 クェン酸、 クェン酸ナトリウム、 ホウ酸、 ホウ砂、 リン酸一水素ナトリウムなど が挙げられる。  Examples of the chelating agent include disodium edetate, ethanehydroxydiphosphate, pyrophosphate, hexametaphosphate, citrate, tartaric acid, and gluconic acid, and examples of the pH adjuster include sodium hydroxide, Triethanolamine, cunic acid, sodium citrate, boric acid, borax, sodium monohydrogen phosphate and the like.
さらに、 紫外線吸収剤としては、 例えば 2—ヒドロキシー 4—メ トキシベンゾ フエノン、 ォクチルジメチル p—ァミノベンゾェ一ト、 ェチルへキシル p—メト キシシンナメートなどが、 紫外線散乱剤としては、 例えば酸化チタン、 カオリン、 タルクなどが挙げられる。  Further, examples of the ultraviolet absorber include 2-hydroxy-4-methoxybenzophenone, octyldimethyl p-aminobenzoate, and ethylhexyl p-methoxycinnamate, and examples of the ultraviolet scattering agent include titanium oxide, kaolin, and talc. No.
また、 ビタミン類としては、 例えばビタミン A、 ビタミン B、 ビタミン C、 ビ 夕ミン D、 ビタミン E、 ビタミン F、 ビタミン 、 ビタミン P、 ビタミン U、 力 ルニチン、 フェルラ酸、 ひ一オリザノール、 ひーリポ酸、 ォロット酸及びその誘 導体などが、 アミノ酸類としては、 例えばグリシン、 ァラニン、 ノ リン、 口イシ ン、 イソロイシン、 セリン、 トレオニン、 フエ二ルァラニン、 チロシン、 トリプ トフアン、 シスチン、 システィン、 メチォニン、 プロリン、 ヒドロキシプロリン、 ァスパラギン酸、 グルタミン酸、 アルギニン、 ヒスチジン、 リジンおよびこれら の誘導体などが挙げられる。 一方、 本発明の医薬品は、 医薬品外用剤基剤の一成分として、 前記の哺乳動物 の耳下腺分泌液から分離された保湿性画分とを含有するものである。 Examples of vitamins include, for example, vitamin A, vitamin B, vitamin C, biyumin D, vitamin E, vitamin F, vitamin, vitamin P, vitamin U, power lunitine, ferulic acid, hi-orizanol, herlipoic acid, Orotic acid and its derivatives include amino acids such as glycine, alanine, norin, oral isin, isoleucine, serine, threonine, fenylalanine, tyrosine, triptophan, cystine, cystine, methionine, proline, and hydroxy. Examples include proline, aspartic acid, glutamic acid, arginine, histidine, lysine and derivatives thereof. On the other hand, the medicament of the present invention contains the moisturizing fraction separated from the parotid gland secretion of the mammal as one component of the medicinal external preparation base.
本発明の医薬品は、 外用剤として皮膚に塗布することにより、 皮膚表面の水分 保持機能を改善することができる。 従来、 医薬品外用剤に添加されている保湿成 分である尿素系化合物の場合、 皮膚の 「ぴりぴり」 感、 疼痛、 紅斑、 搔痒感、 灼 熱感、 落屑、 過敏症などが現れることがあり、 また時には湿疹化、 皮膚の亀裂、 希に腫脹、 乾燥化を生じることがある。  The drug of the present invention can improve the function of retaining water on the skin surface by applying it to the skin as an external preparation. Conventionally, urea-based compounds, which are moisturizing components added to external preparations for pharmaceuticals, may cause skin crispness, pain, erythema, itching, burning, desquamation, hypersensitivity, etc. It can also occasionally cause eczema, skin cracks, rarely swelling and dryness.
本発明の医薬品は、 上記尿素系化合物のような欠点がなく、 ひび、 あかぎれそ の他の皮膚の乾燥に起因する疾患や荒れ肌、 乾燥肌の改善に有効である。 さらに、 皮膚表面の水分保持機能を改善するので、 その医薬品の治療効果を引き出すのに 有利に作用する。  The medicament of the present invention does not have the drawbacks of the above-mentioned urea compounds, and is effective for improving cracks, scabs and other diseases caused by dry skin, rough skin and dry skin. In addition, it improves the water retention function of the skin surface, which is advantageous in bringing out the therapeutic effect of the drug.
本発明の医薬品に含有される前記の本発明に係る保湿性画分 (乾燥状態) の量 は、 その使用目的、 剤型、 他の保湿成分の添加の有無などにもよるが、 通常、 医 薬品全量に基づき 0 . 0 0 1 ~ 2重量%の範囲である。 この含有量が 0 . 0 0 1 重量%未満では保湿機能が充分に発揮されないおそれがあるし、 2重量%を超え ると、 その量の割には効果の向上が認められず、 むしろ経済的に不利となる。 保 湿効果および経済性などを考慮すると、 好ましい含有量は、 0 . 0 0 5〜0 . 2 重量%の範囲である。  The amount of the moisturizing fraction (dry state) according to the present invention contained in the pharmaceutical of the present invention depends on the purpose of use, dosage form, presence or absence of other moisturizing components, and the like. It is in the range of 0.001-2% by weight based on the total amount of the chemical. If the content is less than 0.001% by weight, the moisturizing function may not be sufficiently exerted. If the content exceeds 2% by weight, no improvement in the effect is recognized for the amount, and economical efficiency is obtained. Disadvantaged. In consideration of the moisturizing effect and economy, the preferred content is in the range of 0.05 to 0.2% by weight.
本発明の医薬品において用いられる基剤としては特に制限はなく.、 従来各種剤 型の医薬品外用剤において、 基剤として慣用されている各種成分の中から、 医薬 品の所望剤型に応じて適宜選択することができる。  There is no particular limitation on the base used in the pharmaceutical product of the present invention, and it can be appropriately selected according to the desired dosage form of the pharmaceutical from the various components conventionally used as the base in external preparations of various dosage forms. You can choose.
本発明の医薬品の剤型としては、 特に制限はなく、 例えばクリーム、 軟膏、 口 —シヨンなどが挙げられ、 その基剤が親水性のものであっても、 親油性のもので あっても、 前記の本発明に係る保湿性画分を配合することができる。  The dosage form of the drug of the present invention is not particularly limited, and includes, for example, creams, ointments, mouthwashes, etc., regardless of whether the base is hydrophilic or lipophilic. The moisturizing fraction according to the present invention can be blended.
本発明の医薬品に用いることのできる薬剤は特に限定されず、 外用剤の形態で 投与可能な薬剤であればいずれも使用可能である。 また、 該医薬品は、 所望に応 じ、 例えば前記化粧料の説明において所望成分として例示した各成分を始め、 消 炎剤、 鎮痒剤、 殺菌消毒剤、 感触向上剤、 ホルモン剤などを配合することができ る。 以下に製造例、 試験例および製剤例を挙げて本発明をより詳細に説明するが、 本発明はこれらに限定されるものではない。 The drug that can be used in the pharmaceutical of the present invention is not particularly limited, and any drug that can be administered in the form of an external preparation can be used. In addition, the medicine may contain, as desired, for example, each of the components exemplified as the desired components in the description of the cosmetic, an anti-inflammatory agent, an antipruritic agent, a bactericidal disinfectant, a feel improving agent, a hormonal agent and the like. Can be done. Hereinafter, the present invention will be described in more detail with reference to Production Examples, Test Examples, and Formulation Examples, but the present invention is not limited thereto.
製造例 1 Production Example 1
ゥシの耳下腺分泌液を採取し、 防腐剤としてパラォキシ安息香酸メチルを 0. 15重量%添加し、 冷所に保存した。 この耳下腺分泌液を濾紙 No. 2 (To o Ro shi Ka i s ha, L t d. 製) で濾過し、 その 100リットルを 冷却装置付き抽出機中で、 5〜 10°Cで攪拌しながら 2倍量 (v/v) のァセト ンを加え (アセトン濃度 66. 6% (v/v) ) 、 沈殿を生成させ、 その沈殿を 回収した。 得られた沈殿に適当量のアセトンを加えて脱水し、 アセトンを濾過し て除き、 アセトン脱水ケーキを得た。 これを粉砕し、 風乾してから減圧下 60eC でさらに乾燥し、 ゥシ耳下腺由来の保湿性画分 436 g (収率 0. 44%) を得 た。 得られた保湿性画分の窒素含有量は 0. 13重量%、 タンパク質含有量は 1. 06重量%であった。 The parotid gland secretion was collected, and 0.15% by weight of methyl paraoxybenzoate was added as a preservative and stored in a cool place. The parotid gland secretion was filtered through filter paper No. 2 (Too Roshi Kaisha, Ltd.), and 100 liters thereof were stirred at 5 to 10 ° C in an extractor with a cooling device. While adding twice the amount (v / v) of acetone (acetone concentration: 66.6% (v / v)), a precipitate was formed, and the precipitate was collected. The resulting precipitate was dehydrated by adding an appropriate amount of acetone, and the acetone was removed by filtration to obtain an acetone-dehydrated cake. It was ground, air dried further dried under reduced pressure at 60 e C from to give © sheet parotid derived moisturizing fraction 436 g (yield: 0.44%). The nitrogen content of the obtained moisturizing fraction was 0.13% by weight, and the protein content was 1.06% by weight.
試験例 1 :美肌効果試験 A (官能テスト) Test Example 1: Skin effect test A (sensory test)
上記製造例 1で得られた保湿性画分の皮膚老化防止効果を評価するため、 以下 の要領で美肌効果試験 (官能テスト) を行った。  In order to evaluate the skin aging prevention effect of the moisturizing fraction obtained in Production Example 1, a beautiful skin effect test (sensory test) was performed in the following manner.
保湿性画分 2 Omgに水 1 100ミリリツトルを加えて溶解し、 その全量を曰 本薬局方 「脱脂綿」 (株式会社ェフスリー社製、 カット綿 5 X 5 cm) 200 g に均一に滲み込ませ、 これを加温して乾燥し、 試験試料とした。 なお、 保湿性画 分の含有量は脱脂綿の重量に対して 0. 01重量%とした。  Add 1100 milliliters of water to 2 Omg of the moisturizing fraction, dissolve it, and uniformly infiltrate it into 200 g of `` absorbent cotton '' (made by EF3 Co., Ltd. This was heated and dried to obtain a test sample. The content of the moisturizing fraction was 0.01% by weight based on the weight of absorbent cotton.
次に、 この試料について、 温湯で指掌などが 「かさかさ」 になるまで洗浄した 中高年 (年齢 35〜62歳) 被験者 10名を対象として塗布効果を調べた。 被験 者の手の甲、 指掌試験部位を該カット綿 0. 5 gで軽く十分な回数こすり、 その 後の皮膚感触を回答してもらった。 なお、 塗布後、 手を洗浄することは自由とし た。  Next, the effect of applying this sample to 10 middle-aged (aged 35 to 62) subjects washed with warm water until their fingers and hands became “bulky” was examined. The back of the test subject's hand and the finger / palm test site were rubbed lightly and sufficiently with 0.5 g of the cut cotton, and the skin feeling after that was answered. After application, hands were free to be washed.
試験結果は、 皮膚が 「すべすベ」 し、 「かさかさ感」 が消えたと回答した被験 者が 8名、 「かさかさ感」 が消えたと回答した被験者が 2名であり、 変化なし (無効) と回答した被験者はいなかった。  The test results were as follows: 8 subjects answered that the skin was “smooth” and “bulkyness” had disappeared, and 2 subjects had answered that “bulkyness” had disappeared. No subjects responded.
上記の結果から、 本発明に係る保湿性画分は、 0. 01重量%という低濃度で、 かつ粉末のままで、 優れた保湿機能を有することが分かる。 From the above results, the moisturizing fraction according to the present invention has a low concentration of 0.01% by weight, Also, it can be seen that the powder has an excellent moisturizing function.
試験例 2 :美肌効果試験 B (官能テスト) Test Example 2: Skin effect test B (sensory test)
上記製造例 1で得られた保湿性画分を含む化粧料の皮膚老化防止効果を評価す るため、 以下の要領で美肌効果試験 (官能テスト) を行った。  In order to evaluate the skin aging prevention effect of the cosmetic containing the moisturizing fraction obtained in Production Example 1, a skin beauty effect test (sensory test) was performed in the following manner.
保湿性画分 5 O m gを白色ワセリン 5 0 0 g中に練り込み、 0 . 0 1重量%処 方とした軟膏を調製した。  The moisturizing fraction 5 O mg was kneaded into 500 g of white petrolatum to prepare an ointment treated with 0.01% by weight.
次に、 この軟膏について、 温湯で指掌などが 「かさかさ」 になるまで洗浄した 中高年 (年齢 3 0 ~ 6 0歳) 被験者 1 0名を対象として塗布効果を調べた。 被験 者の指摯試験部位に適量の該軟膏を塗布し、 試験開始前および終了後の状態、 使 用感を回答してもらった。 なお、 ワセリンの 「ベとつき感」 をなくすために、 塗 布後手を洗浄することや拭き取ることは自由とした。  Next, the effect of applying this ointment to 10 middle-aged (aged 30 to 60) subjects washed with warm water until their fingers and hands became “bulky” was examined. The subject applied the appropriate amount of the ointment to the test site, and asked them to answer the condition before and after the test and the feeling of use. In order to eliminate the “stickiness” of Vaseline, hands were free to be washed and wiped off after application.
試験結果は、 皮膚が 「すべすベ」 し、 「かさかさ感」 が消えたと回答した被験 者が 9名、 「かさかさ感」 が消えたと回答した被験者が 1名であり、 変化なし (無効) と回答した被験者はいなかった。  The test results were as follows: 9 subjects answered that their skin was “smooth” and “bulkyness” had disappeared, and 1 subject had answered that “bulkyness” had disappeared. No subjects responded.
上記の結果から、 本発明に係る保湿性画分を含む化粧料は、 油分を喪失した皮 膚に潤いを与えることが分かる。  From the above results, it can be seen that the cosmetic containing the moisturizing fraction according to the present invention gives moisture to the oil-deprived skin.
試験例 3 :荒肌改善効果試験 Test Example 3: Rough skin improvement effect test
上記製造例 1で得られた保湿性画分を含有する化粧料の荒肌改善効果を評価す るための試験を以下の要領で行った。  A test for evaluating the rough skin improving effect of the cosmetic containing the moisturizing fraction obtained in Production Example 1 above was performed in the following manner.
保湿性画分 5 O m gを白色ワセリン 5 0 0 g中に練り混み、 0 . 0 1重量%処 方とした軟膏を調製した。  An ointment prepared by mixing the moisturizing fraction of 5 O mg in 500 g of white petrolatum and treating with 0.01% by weight was prepared.
次に、 荒肌を有する中高年 (年齢 3 0 - 6 5歳) 被験者 1 0名の下脚を対象と して 4週間連続塗布効果を調べた。 被験者の左側下脚試験部位に 1日 1回約 0 . 5 gの該軟膏を塗布し、 試験開始前および終了後の状態を下記の判定基準により 肉眼判定した。 なお、 右側下脚は軟膏を塗布せず (全く処置をせず) 対照とした。  Next, the effect of application on the lower leg of 10 middle-aged and older (aged 30-65) subjects with rough skin was examined for 4 consecutive weeks. About 0.5 g of the ointment was applied to the left lower leg test site of the test subject once a day, and the state before and after the test was visually judged according to the following criteria. The right lower leg was used as a control without ointment (no treatment).
皮虜乾燥度の判定基準  Judgment criteria for skin dryness
一 :正常  One: normal
土 :軽微乾燥、 落屑なし  Soil: slight drying, no desquamation
+ :乾燥、 落屑軽度 + + :乾燥、 落屑中等度 … +: Dry, desquamation + +: Dry, moderate desquamation…
+ + +:乾燥、 落屑顕著  +++: Dry, remarkable desquamation
試験前後の試験部位と対照部位の判定結果を比較し、 皮膚乾燥度が 2段階以上 改善された場合 (例えば、 十 —、 + +→士) を有効とし、 1段階改善された場 合をやや有効、 変化がなかった場合を無効とした。 試験結果は、 有効 8名、 やや 有効 2名、 無効 0名であった。  Compare the results of the test site before and after the test with the control site. If the dryness of the skin is improved by two or more levels (for example, 10-, + + →), it is considered effective. Valid, no change if invalid. The test results were 8 valid, 2 valid, and 0 invalid.
上記の結果から、 本発明に係る保湿性画分を含む化粧料は、 荒肌を改善し、 皮 膚の保湿機能を更新させる効果があることが分かる。  From the above results, it can be seen that the cosmetic containing the moisturizing fraction according to the present invention has the effect of improving rough skin and renewing the moisturizing function of the skin.
試験例 4 :洗浄耐性試験 Test example 4: Cleaning resistance test
本発明に係る保湿性画分の洗浄耐性を評価するため、 後記する製剤例 1 0の処 方を有する、 本発明に係る保湿性画分を含有するバニシングクリームを用いて以 下の試験を行った。  In order to evaluate the washing resistance of the moisturizing fraction according to the present invention, the following test was carried out using a vanishing cream containing the moisturizing fraction according to the present invention, which has the method of Preparation Example 10 described below. Was.
バニシングクリーム 2 gを、 中高年 (年齢 3 0〜6 2歳) 被験者 1 0名に配り、 手の甲、 指掌に 3日間自由に塗布してもらい (勿論その間手を洗浄することは自 由とした) 、 その後はバニシングクリームの塗布を中止した。 バニシングクリ一 ムの塗布中止後、 手を洗浄した後で 「すべすベ」 した感触が消失したときの洗手 回数を回答してもらった。  Distribute 2 g of burnishing cream to 10 subjects of middle-aged and elderly (age 30 to 62), and apply it freely to the back of hands and palms for 3 days. Then, the application of the burnishing cream was stopped. After the application of the burnishing cream, the number of hand washings when the “smooth” feel disappeared after washing the hands was asked.
試験結果は、 5回以上の洗浄によっても 「すべすベ」 感が消失しなかったと答 えた被験者 3名、 4回で 「すべすベ」 感が消失したと答えた被験者 5名、 以下、 3回と答えた被験者 1名、 2回と答えた被験者 1名で、 1回の洗浄で 「すべす ベ」 感が消失したと答えた被験者はいなかった。  The test results were as follows: 3 subjects who answered that the feeling of "smooth" did not disappear even after washing 5 times or more, 5 subjects who answered that the feeling of "smooth" did not disappear after 4 times, etc. None of the subjects answered one time and one subject answered twice, and none of the subjects answered that the feeling of “smoothness” disappeared by one washing.
上記の結果から、 本発明に係る保湿性画分を含む化粧料は、 数回の洗浄によつ ても、 その保湿皮膜が落ちず、 保湿性が保持されることが分かる。  From the above results, it can be seen that the cosmetic containing the moisturizing fraction according to the present invention does not lose its moisturizing film even after several washings, and retains its moisturizing properties.
次に製剤例を示す。 各製剤例の各成分の配合割合の数値は 「重量%」 を表す。 製剤例 1 :化粧水  Next, formulation examples are shown. The numerical value of the mixing ratio of each component in each formulation example represents "% by weight". Formulation Example 1: Lotion
1 , 3—ブチレングリコ一ル 2 . 0  1,3-butylene glycol 2.0
エタノール 1 0 . 0  Ethanol 10.0
パラォキシ安息香酸メチル 0 . 1  Methyl paraoxybenzoate 0.1
ゥシ耳下腺分泌液由来保湿性画分 0 . 0 1 香料 Moisturizing fraction from parotid gland secretion 0.0 1 Spice
精製水 残  Purified water residue
本発明に係る保湿性画分を含有する上記処方を有する化粧水は、 皮膚に潤いを 持たせ、 「すべすベ」 した肌を作り、 以下の製剤例化粧料の肌への乗りを極めて 良くした。  The lotion having the above-mentioned formula containing the moisturizing fraction according to the present invention moisturizes the skin and creates a "smooth" skin, and the following formulation examples make cosmetics extremely good on the skin. did.
製剤例 2 :乳液 Formulation Example 2: Emulsion
1, 3—ブチレングリコ一ル 3 0 スクヮラン 2 0 ステ 'ァリン酸 2 0 流動パラフィン 6 0 ソルビ夕ンモノステアレート 1 5 ポリオキシエチレン(20)ソルビタンモノステアレート 2 0 パラォキシ安息香酸ブチル 0 05 パラォキシ安息香酸メチル 0 1 ゥシ耳下腺分泌液由来保湿性画分 0 01 香料  1,3-butylene glycol 3 0 squalane 2 0 stearic acid 2 0 liquid paraffin 6 0 sorbitan monostearate 1 5 polyoxyethylene (20) sorbitan monostearate 2 0 butyl parahydroxybenzoate 0 05 paraoxy Methyl benzoate 0 1 Moisturizing fraction from parotid gland secretion 0 01 Fragrance
精製水 残余  Purified water residue
製剤例 3 :スキンローション Formulation Example 3: Skin lotion
エタノール 10. 0  Ethanol 10.0
1, 3—ブチレングリコール 2. 0 グリセリン 5. 0 パラォキシ安息香酸メチル 0. 1 ゥシ耳下腺分泌液由来保湿性画分 0. 02 精製水 残余  1, 3-butylene glycol 2.0 Glycerin 5.0 Methyl paraoxybenzoate 0.1 Moisturizing fraction derived from parotid gland secretion 0.02 Purified water residue
製剤例 4 :スキンミルク Formulation Example 4: Skin milk
流動パラフィン 10 0 セ夕ノール 2 0 コレステリン 0 5 モノグリセライ ド 1 0 ポリオキシエチレン(6)ソルビ夕ンモノォレエ一ト 5. 0 ゥシ耳下腺分泌液由来保湿性画分 0. 02 精製水 残余 Liquid paraffin 10 0 SENOLUNO 2 0 Cholesterin 0 5 Monoglyceride 1 0 Polyoxyethylene (6) sorbitan monohydrate 5.0 Moisturizing fraction derived from parotid gland secretion 0.02 Purified water Residue
製剤例 5 :マッサージミルク Formulation Example 5: Massage milk
オリ一ブ油 10. 0 ミリスチン酸ォクチルドデシル 10. 0 スクヮラン 10. 0 セ夕ノール 2. 0 ポリオキシエチレン(5.5)セチルエーテル 8. 0 ポリオキシエチレン(20)ソルビ夕ントリオレエート 5. 0 ゥシ耳下腺分泌液由来保湿性画分 0. 02 精製水 残余  Olive oil 10.0 Octyldodecyl myristate 10.0 Squalane 10.0 Senoyl 2.0 Polyoxyethylene (5.5) cetyl ether 8.0 Polyoxyethylene (20) Sorbi quinone trioleate 5.0 ゥMoisturizing fraction derived from parotid gland secretion 0.02 Purified water residue
製剤例 6 :毛髪基礎調整水 Formulation Example 6: Hair base conditioning water
1, 3—ブチレングリコール 2. 0 エタノール 10. 0 ポリオキシエチレン硬化ヒマシ油 10 0. 05 パラォキシ安息香酸メチル 0. 1 ゥシ耳下腺分泌液由来保湿性画分 0. 02 精製水 残余  1,3-Butylene glycol 2.0 Ethanol 10.0 Polyoxyethylene hydrogenated castor oil 10 0.05 Methyl parahydroxybenzoate 0.1 Moisturizing fraction from parotid gland secretion 0.02 Purified water residue
本発明に係る保湿性画分を含有する上記毛髪基礎調整水は、 洗髪後数ミリリッ トルをとり、 毛髪および頭皮に塗布すると、 毛髪は 「すべすベ」 になり、 その後 の整髪料の乗りや櫛通りを極めて改善した。 また、 頭皮には潤いを持たせ、 水分 保持機能を亢進させ、 乾燥を改善した。  The above-mentioned hair base conditioning water containing the moisturizing fraction according to the present invention takes a few milliliters after shampooing, and when applied to hair and scalp, the hair becomes `` smooth '' and the hair styling material can be used thereafter. The combing was greatly improved. It also moisturized the scalp, enhanced the water retention function, and improved drying.
製剤例 7 :ヘアリンス Formulation Example 7: Hair rinse
セ夕ノール 1. 0  Seunor Knoll 1.0
1, 3—ブチレングリコール 3. 0 塩化ステアリルトリメチルアンモニゥム 4. 5 ステアリン酸 0. 5 モノステアリン酸 1. 0 ポリオキシエチレン(2)ォレイルエーテル 3. 5 パラォキシ安息香酸メチル 0. 1 ゥシ耳下腺分泌液由来保湿性画分 0. 02 精製水 残余 製剤例 8 :ハンドクリーム 1,3-butylene glycol 3.0 stearyltrimethylammonium chloride 4.5 stearic acid 0.5 monostearic acid 1.0 Polyoxyethylene (2) oleyl ether 3.5 Methyl paraoxybenzoate 0.1 Moisturizing fraction derived from parotid gland secretion 0.02 Purified water Residue Formulation example 8: Hand cream
白色ワセリン 40. 0 スクヮラン 20. 0 セレシン 5 , 0 ソゾレビ夕ンセスキォレエ一ト 3, 0 ポリオキシエチレンソルビ夕ンモノォレエート 0 8 プロピレングリコール 3 0 パラォキシ安息香酸メチル 0 1 ゥシ耳下腺分泌液由来保湿性画分 0 01 香料  White petrolatum 40.0 squalane 20.0 ceresin 5,0 sozorebi sesquioleate 3,0 polyoxyethylene sorbitan monooleate 0 8 propylene glycol 3 0 methyl parabenzoate 0 1 moisturizing oil derived from parotid gland secretion Min 0 01 fragrance
精製水 残余 製剤例 9 :コールドクリーム  Purified water Residue Formulation Example 9: Cold cream
白色ヮセリン 40. 0 セ夕ノール 10. 0 サラシミツロウ 5.. 0 ソルビ夕ンセスキォレエ一ト 5 0 ラウロマクロゴール 0 5 パラォキシ安息香酸メチル 0 1 パラォキシ安息香酸プロビル 0 1 ゥシ耳下腺分泌液由来保湿性画分 0 01 香料  White ヮ serine 40.0 Cenosol 10.0 Salami beeswax 5.0.0 Sorbine sesquioleate 5 0 Lauromacrogol 0 5 Methyl paraoxybenzoate 0 1 Provir paraoxybenzoate 0 1 Moisturizing water from parotid gland secretion Sex fraction 0 01 Fragrance
精製水 残余 製剤例 10 :バニシングクリーム  Purified water Residue Formulation Example 10: Vanishing cream
白色ヮセリン 25. 0 ステアリルアルコール 20. 0 プロピレングリコール 2 · -0 ポリオキシエチレン硬化ヒマシ油 6 0 4 . 0 モノステアリン酸グリセリン 1 0 パラォキシ安息香酸メチル 0 1 パラォキシ安息香酸プロビル 0 1 ゥシ耳下腺分泌液由来保湿性画分 0 0 1 香料 White Pserin 25.0 Stearyl alcohol 20.0 Propylene glycol 2 · -0 Polyoxyethylene hydrogenated castor oil 64.0 Glycerin monostearate 10 0 Methyl parahydroxybenzoate 0 1 Provyl paraoxybenzoate 0 1 Moisturizing fraction from parotid gland secretion 0 0 1 Spice
精製水 残余 製剤例 1 1 :スキンクリーム  Purified water Residue Formulation example 11 1: Skin cream
流動パラフィン 1 5 0 サラシミツロウ 3 0 ステアリン酸 3 . 0 ソ レビ夕ンセスキォレエ一ト 3 . 0 セ夕ノール 2 . 5 ポリオキシエチレン(20)ソルビ夕ンモノォレエ一ト 4 . 0 グリセリン 5 . 0 パラォキシ安息香酸メチル 0 . 1 Liquid paraffin 1 5 5 Beeswax 3 3 0 Stearic acid 3 0 3.0 Sesinolate 3 0 3.0 Selenol 2.5 Polyoxyethylene (20) Sorbines monooleate 4 0 4 Glycerin 5.0 Paraoxybenzoic acid Methyl 0.1
N—ラウロイルー L—グル夕ミン酸ナトリウム 0 . 2 ゥシ耳下腺分泌液由来保湿性画分 0 . 0 2 精製水 残余 製剤例 1 2 :ナイ トクリーム N-lauroylu L-Glutamate sodium 0.2% Moisturizing fraction from parotid gland secretion 0.02 Purified water Residue Formulation example 12 2: Night cream
流動パラフィン 1 5 . 0 スクヮラン 1 5 , 0 モノグリセライ ド 2 , 0 コレステリン 1 , 0 セ夕ノール 2 0 セチルパルミテ一ト 1 0 ラノリン 3 0 ポリォキシエチレン(7)セチルエーテル 8 0 ソルビトール 5 . 0 パラォキシ安息香酸メチル 0 . 1 ゥシ耳下腺分泌液由来保湿性画分 0 . 0 2 精製水 残余 産業上の利用可能性 Liquid paraffin 15.0 Squalane 15, 0 Monoglyceride 2,0 Cholesterin 1,0 Ceanol 1 0 Cetyl palmitate 1 0 Lanolin 3 0 Polyoxyethylene (7) cetyl ether 8 0 Sorbitol 5.0 Methyl paraoxybenzoate 0.1 Moisturizing fraction from parotid gland secretion 0.0 2 Purified water Residual Industrial availability
本発明の保湿剤、 化粧料および医薬品は、 哺乳動物の耳下腺分泌液由来の保湿 性画分を有効成分として含有するものであって、 該保湿性画分は、 極めて微量で 保湿機能を発揮し、 皮膚の水分保持機能を亢進させることができる。  The humectant, cosmetic and pharmaceutical product of the present invention contain a moisturizing fraction derived from a parotid gland secretion of a mammal as an active ingredient, and the moisturizing fraction has a very small amount of a moisturizing function. It can exert and enhance the moisture retention function of the skin.
本発明の保湿剤、 化粧料および医薬品は、 「ベとつき」 などの違和感を伴うこ となく、 皮膚を 「しっとり」 させ、 また、 頭髪の滑りを良くすることができる。 さらに、 保湿機能の持続性が高く、 数回の水や温湯による洗浄によっても、 皮膚 表面の保湿性皮膜が落ちない。  The moisturizer, cosmetics and pharmaceuticals of the present invention can make the skin "moist" and improve the slip of the hair without causing discomfort such as "stickiness". Furthermore, the moisturizing function is highly durable, and even after several washings with water or hot water, the moisturizing film on the skin surface does not fall off.
また、 該保湿性画分を医薬品外用剤に配合することにより、 皮膚表面の水分保 持機能を改善し、 その医薬の薬効を引き出すのに有利に作用する。  In addition, by blending the moisturizing fraction into an external preparation for medicine, the function of retaining moisture on the skin surface is improved, and it works advantageously to bring out the medicinal properties of the medicine.

Claims

請求の範囲 - The scope of the claims -
1. 哺乳動物の耳下腺分泌液の水混和性有機溶剤の濃度 60% (v/v) 以上で 沈殿する画分を有効成分として含有することを特徴とする保湿剤。 1. A moisturizer characterized by containing, as an active ingredient, a fraction that precipitates at a water-miscible organic solvent concentration of 60% (v / v) or higher in the parotid gland secretion of mammals.
2. 水混和性有機溶剤の濃度が 63〜 80 % (v/v) である請求の範囲第 1項 に記載の保湿剤。  2. The humectant according to claim 1, wherein the concentration of the water-miscible organic solvent is 63 to 80% (v / v).
3. 水混和性有機溶剤がァセトンである請求の範囲第 1項に記載の保湿剤。  3. The humectant according to claim 1, wherein the water-miscible organic solvent is acetone.
4. 哺乳動物がゥシである請求の範囲第 1項に記載の保湿剤。  4. The humectant according to claim 1, wherein the mammal is a fish.
5. 哺乳動物の耳下腺分泌液の水混和性有機溶剤の濃度 60% (v/v) 以上で 沈殿する画分が、 窒素含有量 0. 05〜0. 4重量%で、 タンパク質含有量 0. 4〜 3重量%のものである請求の範囲第 1項に記載の保湿剤。  5. The fraction that precipitates at a water-miscible organic solvent concentration of 60% (v / v) or higher in the parotid glands of mammals has a nitrogen content of 0.05 to 0.4% by weight and a protein content of 0.05% to 0.4% by weight. 2. The humectant according to claim 1, wherein the humectant is 0.4 to 3% by weight.
6. 請求の範囲第 1項に記載の保湿剤を皮膚に塗布することを特徴とする皮膚の 保湿方法。 6. A method for moisturizing the skin, comprising applying the moisturizing agent according to claim 1 to the skin.
7. 請求の範囲第 1項に記載の保湿剤を、 頭髪または頭皮あるいはその両方に塗 布することを特徴とする頭髪 ·頭皮の保湿方法。  7. A method for moisturizing hair and scalp, which comprises applying the humectant according to claim 1 to the hair and / or scalp.
8. 化粧料基剤と、 哺乳動物の耳下腺分泌液の水混和性有機溶剤の濃度 60 % (v/v) 以上で沈殿する画分とを含有することを特徴とする化粧料。  8. A cosmetic, comprising: a cosmetic base; and a fraction that precipitates at a water-miscible organic solvent concentration of 60% (v / v) or more in the parotid gland secretion of mammals.
9. 哺乳動物の耳下腺分泌液の水混和性有機溶剤の濃度 60% (v/v) 以上で 沈殿する画分の含有量が 0. 001〜 2重量%である請求の範囲第 8項に記載の 化粧料。  9. The content of the fraction precipitated at a water-miscible organic solvent concentration of 60% (v / v) or higher in the parotid gland secretion of mammals of 0.001 to 2% by weight. Cosmetics according to.
10. 水混和性有機溶剤の濃度が 63〜80% (v/v) である請求の範囲第 8 項に記載の化粧料。  10. The cosmetic according to claim 8, wherein the concentration of the water-miscible organic solvent is 63 to 80% (v / v).
1 1. 水混和性有機溶剤がアセトンである請求の範囲第 8項に記載の化粧料。 1 1. The cosmetic according to claim 8, wherein the water-miscible organic solvent is acetone.
12. 哺乳動物がゥシである請求の範囲第 8項に記載の化粧料。 12. The cosmetic according to claim 8, wherein the mammal is an insect.
13. 哺乳動物の耳下腺分泌液の水混和性有機溶剤の濃度 60% (v/v) 以上 で沈殿する画分が、 窒素含有量 0. 05〜0. 4重量%で、 タンパク質含有量 0. 4〜 3重量%のものである請求の範囲第 8項に記載の化粧料。  13. The fraction that precipitates at a water-miscible organic solvent concentration of 60% (v / v) or higher in the parotid gland secretion of mammals has a nitrogen content of 0.05 to 0.4% by weight and a protein content of 9. The cosmetic according to claim 8, which is in an amount of 0.4 to 3% by weight.
14. 皮膚化粧料または毛髪化粧料である請求の範囲第 8項に記載の化粧料。 14. The cosmetic according to claim 8, which is a skin cosmetic or a hair cosmetic.
15. 皮膚化粧料が化粧水、 乳液、 パック剤、 クリーム類、 ローション、 口紅、 ファンデーションまたは皮膚洗浄剤である請求の範囲第 14項に記載の化粧料。15. Skin cosmetics are lotions, emulsions, packs, creams, lotions, lipsticks, 15. The cosmetic according to claim 14, which is a foundation or a skin cleanser.
16. 毛髪化粧料が毛髪基礎調整水、 ヘアリンス、 ヘア一トニック、 ヘアークリ —ムまたはヘア一ローションである請求の範囲第 14項に記載の化粧料。 16. The cosmetic according to claim 14, wherein the hair cosmetic is a hair base conditioning water, a hair rinse, a hair tonic, a hair cream or a hair lotion.
17. 医薬品外用剤基剤の一成分として、 哺乳動物の耳下腺分泌液の水混和性有 機溶剤の濃度 60% (v/v)以上で沈殿する画分を含有することを特徴とする 医薬品。  17. It contains a fraction that precipitates at a concentration of 60% (v / v) of a water-miscible organic solvent in the parotid gland of mammals as a component of the base for external preparations for pharmaceuticals. Pharmaceuticals.
18. 哺乳動物の耳下腺分泌液の水混和性有機溶剤の濃度 60% (v/v)以上 で沈殿する画分の含有量が 0. 001〜 2重量%である請求の範囲第 17項に記 載の医紫品。  18. The content of the fraction precipitated at a water-miscible organic solvent concentration of 60% (v / v) or more in the parotid gland secretion of mammals of 0.001 to 2% by weight. Medical purple goods listed in.
19. 水混和性有機溶剤の濃度が 63〜80% (v/v)である請求の範囲第 1 7項に記載の医薬品。  19. The pharmaceutical according to claim 17, wherein the concentration of the water-miscible organic solvent is 63 to 80% (v / v).
20. 水混和性有機溶剤がアセトンである請求の範囲第 17項に記載の医薬品。 20. The pharmaceutical product according to claim 17, wherein the water-miscible organic solvent is acetone.
21. 哺乳動物がゥシである請求の範囲第 17項に記載の医薬品。 21. The medicament according to claim 17, wherein the mammal is a mammal.
22. 哺乳動物の耳下腺分泌液の水混和性有機溶剤の濃度 60% (v/v)以上 で沈殿する画分が、 窒素含有量 0. 05~0. 4重量%で、 タンパク質含有量 0. 22. The fraction that precipitates at a water-miscible organic solvent concentration of 60% (v / v) or higher in the parotid gland secretion of mammals has a nitrogen content of 0.05 to 0.4% by weight and a protein content of 0.
4-3重量%のものである請求の範囲第 17項に記載の医薬品。 18. The drug according to claim 17, which is 4-3% by weight.
23. クリーム、 軟膏およびローションの中から選ばれる医薬品外用剤である請 求の範囲第 17項に記載の医薬品。  23. The medicament according to claim 17, which is an external preparation selected from creams, ointments and lotions.
PCT/JP1998/001929 1997-04-28 1998-04-27 Humectant, and cosmetic preparation and medicine both containing the same WO1998048767A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP54682098A JP4424759B2 (en) 1997-04-28 1998-04-27 Moisturizer, cosmetics and pharmaceuticals containing it

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9/110586 1997-04-28
JP11058697 1997-04-28

Publications (1)

Publication Number Publication Date
WO1998048767A1 true WO1998048767A1 (en) 1998-11-05

Family

ID=14539617

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1998/001929 WO1998048767A1 (en) 1997-04-28 1998-04-27 Humectant, and cosmetic preparation and medicine both containing the same

Country Status (2)

Country Link
JP (1) JP4424759B2 (en)
WO (1) WO1998048767A1 (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53104714A (en) * 1977-01-25 1978-09-12 Teikoku Hormone Mfg Co Ltd Compound proteins having serum calcium decreasing, immunity promoting actions and their preparation
JPS57500562A (en) * 1980-04-25 1982-04-01
JPS60115527A (en) * 1983-11-25 1985-06-22 Teikoku Hormone Mfg Co Ltd Substance for promoting transport of dental fluid and its production
JPS61129038A (en) * 1984-11-28 1986-06-17 Iwase Kosufua Kk Emulsifier composition
JPS61210013A (en) * 1985-03-13 1986-09-18 Iwase Kosufua Kk External preparation for skin
JPS6289610A (en) * 1985-06-05 1987-04-24 Pola Chem Ind Inc Cosmetic
JPH05310799A (en) * 1992-05-11 1993-11-22 Teikoku Hormone Mfg Co Ltd Method for purifying mucin

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53104714A (en) * 1977-01-25 1978-09-12 Teikoku Hormone Mfg Co Ltd Compound proteins having serum calcium decreasing, immunity promoting actions and their preparation
JPS57500562A (en) * 1980-04-25 1982-04-01
JPS60115527A (en) * 1983-11-25 1985-06-22 Teikoku Hormone Mfg Co Ltd Substance for promoting transport of dental fluid and its production
JPS61129038A (en) * 1984-11-28 1986-06-17 Iwase Kosufua Kk Emulsifier composition
JPS61210013A (en) * 1985-03-13 1986-09-18 Iwase Kosufua Kk External preparation for skin
JPS6289610A (en) * 1985-06-05 1987-04-24 Pola Chem Ind Inc Cosmetic
JPH05310799A (en) * 1992-05-11 1993-11-22 Teikoku Hormone Mfg Co Ltd Method for purifying mucin

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"LECTURES ON BIOCHEMICAL EXPERIMENTS", CARBOHYDRATE CHEMISTRY, XX, XX, vol. 04, no. PART 01, 1 January 1976 (1976-01-01), XX, pages 155 - 170, XP002917123 *

Also Published As

Publication number Publication date
JP4424759B2 (en) 2010-03-03

Similar Documents

Publication Publication Date Title
JP4904811B2 (en) External preparation for skin comprising a carbohydrate derivative of α, α-trehalose
JP3513873B2 (en) External preparation for skin
JP4729343B2 (en) Use of a composition comprising at least one chelating agent for increasing the tolerance limit of sensitive or intolerant skin
JP3112436B2 (en) In particular, the use of honey as a keratolytic agent to improve the brightness of the skin facial and treat wrinkles
JPH0552806B2 (en)
US20170246106A1 (en) Methods and compositions for maintaining and improving the health of skin
JPH06279227A (en) Dermatic external preparation and cosmetic
JP2005187474A (en) Improved scented cosmetic
JPS62292710A (en) Skin cosmetic
CA2365660A1 (en) Treatment for skin
JP3172753B2 (en) Biological hyaluronic acid synthesis promoter
JP4056570B2 (en) Lemongrass extract-containing cosmetic
WO1999022709A1 (en) Cosmetics and process for the preparation of extract of the nest of $i(oceanodroma sp.)
JP2017193506A (en) Skin Cosmetic
JPH11139951A (en) Cosmetic
JP3658626B2 (en) Cosmetics and quasi drugs
JPH03112912A (en) Cosmetic composition
JPH04134012A (en) Sebum secretion promoter
JP2000344697A (en) Long-chain branched alcohol and cosmetic and external preparation produced by using the alcohol
JP4424759B2 (en) Moisturizer, cosmetics and pharmaceuticals containing it
GB1591852A (en) Cosmetic compositions
JPH08157337A (en) Hair cosmetic
JPH08259443A (en) Dermal composition for external use
JPH08259420A (en) Composition for skin external preparation
JP2780805B2 (en) New skin external preparation composition

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase